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Abstract 
Approximately 25% of the world’s population is infected with Mycobacterium tuberculosis 
(M.tuberculosis). Progression to active tuberculosis (TB) is influenced by the infecting strain of 
M.tuberculosis, the environment and the genetic makeup of the host. Globally, the incidence rate for 
TB in males is nearly twice as high compared to females, indicating that biological sex of an individual 
also contributes to TB susceptibility. While environmental factors and sex hormones influence the 
immune system and affect the male bias, they do not fully account for it. This suggests that the X 
chromosome and the unique biology regulating X-linked gene expression in females could 
significantly influence progression to active TB. 
The X chromosome contains nearly 200 genes that are involved in the immune system. This clearly 
links the X chromosome to both the innate and humoral immune response and could explain why 
females have a more robust immune response against infections. X-linked genes have also been 
implicated in TB susceptibility, but these have not been conclusively linked to disease. Population 
specific effects could further contribute to the impact of the X chromosome on disease progression 
especially for populations that experienced sex-biased admixture.  
Here we investigated the five way admixed South African Coloured (SAC) population that has sex-
specific genetic contributions from Bantu-speaking African, European, KhoeSan and South and East 
Asian populations. We showed that global ancestry inference could be used to detect the presence 
of sex-biased admixture and that this correlates with previous results indicating a KhoeSan female 
bias and a European and Bantu-speaking African male bias. 
We used SAC genome-wide association (GWAS) data and analysed the autosomes and X 
chromosome in a sex-stratified and combined manner, revealing sex-specific effects on both the 
autosome and X chromosome. A genome-wide interaction analysis also revealed significant 
interactions highlighting the need for epistatic and sex-stratified analysis in complex diseases. 
X chromosome data from the International Tuberculosis Host Genetic Consortium (ITHGC) was 
available to conduct a large trans-ethnic X-linked meta-analysis of TB susceptibility. The meta-
analysis included imputed GWAS data from two Chinese, one Russian, a Ghanaian and Gambian 
and two SAC cohorts (23229 samples). We optimised imputation in our SAC data and showed that 
even diverse African populations can be imputed with great accuracy. The meta-analysis revealed 
novel X-linked genes associated with TB susceptibility. These genes were located in genomic regions 
on the X chromosome previously associated with TB susceptibility. Results from the meta-analysis 
also further confirmed the presence of both sex-specific and population specific effects.  
Our work highlights the importance of not only conducting sex-stratified analysis to elucidate sex-
specific effects, but also to plan the study accordingly. Due to the strong impact of population specific 
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effects, extremely large meta-analysis will be needed to fully elucidate global and population specific 
susceptibility variants. While the X chromosome has been mostly neglected in the past, tools for its 
analysis are now readily available. Our findings support the mandatory inclusion of the X chromosome 
in large-scale genetic studies. 
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Opsomming 
Ongeveer 25% van die wêreld se bevolking is geïnfekteer met Mikobacterium tuberculosis. Die 
ontwikkeling van aktiewe tuberkulose (TB) word beïnvloed deur die bakterium, die omgewing en die 
genetiese komponent van die gasheer. Die siekte tas twee keer soveel mans as vroue aan, wat 
aandui dat biologiese geslag ook bydra tot TB vatbaarheid. Alhoewel beide omgewingsfaktore en 
geslagshormone die immuunstelsel sowel as die TB geslagsvooroordeel beïnvloed, is dit nie ten volle 
daarvoor verantwoordelik nie. Dit dui daarop dat die X-chromosoom en die unieke biologie wat X-
gekoppelde geenuitdrukking in vroue reguleer aansienlik kan bydra tot die ontwikkeling van aktiewe 
TB. 
Die X-chromosoom bevat byna 200 gene wat by die immuunstelsel betrokke is. Hierdie gene verbind 
die X-chromosoom aan beide die aangebore en humorale immuunrespons en kan verduidelik 
waarom vroue 'n sterker immuunrespons teen infeksies het. X-gekoppelde gene is ook betrek by TB 
vatbaarheid, maar dit is nie voldoende verbind aan die siekte nie. Bevolkingspesifieke effekte kan 
verder bydra tot die impak van die X-chromosoom op die ontwikkeling van die siekte, veral vir 
bevolkings waar genetiese vermenging met geslagsvooroordeel plaas gevind het. 
Hierdie tesis ondersoek Suid-Afrikaanse individue (SAC) wat geslags-spesifieke genetiese 
vermenging het van Bantoe-sprekende Afrikane-, Europese, KhoeSan- en Suid- en Oos-Asiatiese 
bevolkings. Ons wys dat globale vermenging inferensie gebruik kan word om die teenwoordigheid 
van geslagsvooroordeel te bepaal en dat dit korreleer met vorige resultate wat dui op 'n vroulike 
KhoeSan vooroordeel en 'n manlike Europese en Bantoe-sprekende Afrika vooroordeel. 
Ons gebruik SAC genoom-wye assosiasie (GWAS) data en ontleed die outosoom- en X-chromosoom 
op 'n geslags-gestratifiseerde en gekombineerde wyse, wat geslags-spesifieke effekte op beide die 
autosome en X-chromosoom openbaar. 'n Genoom-wye interaksie-analise het ook betekenisvolle 
interaksies aangedui wat die nut van epistatiese en geslags-gestratifiseerde analise in komplekse 
siektes beklemtoon. 
X chromosoom data van die Internasionale Tuberkulose gasheer genetiese konsortium (ITHGC) was 
beskikbaar om 'n groot transetniese X-gekoppelde meta-analise van TB-vatbaarheid uit te voer. Die 
meta-analise het toegepaste GWAS data van twee Chinese, een Russiese, 'n Ghanese en Gambiese 
en twee SAC versamelings (23229 monsters) ingesluit. Ons het toerekening in ons SAC-data 
optimiseer en toon dat selfs diverse Afrika-bevolkings met groot akkuraatheid toegereken kan word. 
Die meta-analise onthul nuwe X-gekoppelde gene wat verband hou met TB-vatbaarheid. Hierdie gene 
word gevind in genomiese streke op die X-chromosoom wat voorheen geassosieer is met TB-
vatbaarheid. Resultate van die meta-analise bevestig verder die teenwoordigheid van beide 
gespesifiseerde en populasie spesifieke effekte. 
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Ons werk beklemtoon die belangrikheid van nie net geslags-gestratifiseerde analise om geslags-
spesifieke effekte te verduidelik nie, maar ook om die studie dienooreenkomstig te beplan. As gevolg 
van die sterk impak van bevolkingspesifieke effekte sal uiters groot meta-analise nodig wees om 
globale en populasie spesifieke vatbaarheidsvariante ten volle te verklaar. Alhoewel die X-
chromosoom in die verlede meestal verwaarloos tydens genetiese analise, is die gereedskap 
daarvoor nou beskikbaar. Ons bevindinge ondersteun die verpligte insluiting van die X-chromosoom 
in grootskaalse genetiese studies. 
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1 General Introduction 
1.1 Brief history of Tuberculosis  
Mycobacterium tuberculosis (M.tuberculosis), the causative agent of tuberculosis (TB), interacted with 
the human host for most of human history, during which M. tuberculosis has perfectly adapted to its 
environment (1). Early evidence of M. tuberculosis infection was found in skeletal remains from the 
Iron Age (400-230 BC) and exhumed mummies from Egypt (2–5). At first, TB was thought to be a 
hereditary disease as it seemed to cluster within families, but in 1699 Gaspart Laurant Bale 
discovered that tubercles were the cause of TB and for the first time the infectious nature of TB was 
proposed (6,7). Soon after this discovery Europe was hit by the “Great White Plague”, the biggest TB 
epidemic in history which lasted over 200 years from the early 18th century to the late 19th century (8). 
During this time advances were made in understanding the disease. In 1720 Benjamin Marten 
expanded on the discovery by Gaspart Laurant and proposed that TB is caused by minute living 
creatures residing in the tubercles, which can be transmitted through close contact (9). In 1839 Johan 
Lucas Schönlein termed the disease Tuberculosis, after the tubercles that caused it (8). In 1882, 
Robert Koch identified M. tuberculosis as the TB-causing agent. (10–12). Koch also identified the 
tuberculin compound, which led to the development of the Tuberculin Skin Test (TST) that is used as 
a proxy for M. tuberculosis infection, but not active disease (13–16). The discovery of X-ray 
technology by Wilhelm Conrad von Röntgen in 1895 allowed for an alternative detection tool for 
detecting active TB, a tool still in use (17).  
Following the discovery of these detection methods, further progress was made against the disease 
in the 20th century. In 1908 Albert Calmette and Camille Guérin created the Bacille Calmette-Guerin 
(BCG) strain from an attenuated strain of M. tuberculosis (10,18). The BCG vaccine against M. 
tuberculosis was first administered to humans in 1921 and administered on a large scale to children 
in Europe after the second world war (1945-1948) (19). Meta-analysis on the efficacy of BCG 
vaccination revealed a protective efficacy of 19% against infection and 58% protection against 
developing active TB, but only in children (20). During the second world war (1943) the first antibiotic, 
streptomycin, was developed which was soon followed by the development of the second anti-TB 
drug, para-aminosalicylic acid (PAS) in 1947 (21–23). Then in 1960, following the discovery of 
isoniazid (INH) in 1952, TB was considered a 100% curable disease, a thought that persisted until 
the first outbreak of drug resistant TB in the United States of America (USA) in the 1970’s (8,22,24). 
Drug resistant M. tuberculosis, remains to this day the biggest hurdle to eradicating the disease (25). 
A genetic nomenclature of scientific terms and concepts used in this thesis is given in Table 1.1 below.  
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Table 1.1: Genetic nomenclature 
Term Definition 
95% Confidence 
interval 
Range of values so defined that there is a specified probability that the 
value of a parameter lies within it. (95%CI) 
Allele Refers to a particular form occurring at a locus. In humans, each individual 
will have a maximum of two forms, since it is possible that their parents 
differed from each other at this locus and that the individual inherited a 
different form from each parent. 
Allelic association Statistical analysis to determine whether disease is associated with 
particular allelic variants at one or more loci, usually by comparing marker 
allele frequencies between a disease group and a control group. 
Association by LD Association with a marker in strong LD with the causal locus. Also known 
as indirect association. 
Bias Inclination or prejudice for or against one person or group. 
Candidate gene Genetic association studies that focus on associations between genetic 
variation within pre-specified genes of interest and phenotypes or disease 
states. 
Effective population 
size 
The number of individuals in a population who contribute offspring to the 
next generation. 
False positive 
associations 
Association due to confounding by stratification between cases and 
controls. Also known as confounded association. 
Fine-mapping Determine the genetic variant (or variants) responsible for complex traits, 
given evidence of an association of a genomic region with a trait.  
Genotype A description of the two alleles at a given locus. 
Genome-wide 
association study 
Observational study of a genome-wide set of genetic variants in different 
individuals to see if any variant is associated with a trait. (GWAS) 
Haplotype A section of DNA on a single chromosome where certain alleles of different 
markers tend to be inherited as a unit. 
Heterogeneous  There are two types of genetic heterogeneity: allelic heterogeneity, which 
occurs when a similar phenotype is produced by different alleles within the 
same gene; and locus heterogeneity, which occurs when a similar 
phenotype is produced by mutations at different loci. 
Heterozygosity A measure of genetic diversity within a population. 
Hardy-Weinberg 
equilibrium 
The Hardy–Weinberg principle, also known as the Hardy–Weinberg 
equilibrium, model, theorem, or law, states that allele and genotype 
frequencies in a population will remain constant from generation to 
generation in the absence of other evolutionary influences. (HWE) 
Imputation Statistical inference of unobserved genotypes. 
Lineage Direct descent from an ancestor; ancestry or pedigree. 
Linkage analysis Statistical analysis to localise genes and markers with respect to each 
other in the genome, based on recombination frequency. Linkage analysis 
can also be used to map a disease phenotype in relation to polymorphic 
markers. 
Linkage 
disequilibrium 
The non-random association of alleles at different loci. (LD) 
 
Locus A specific position in DNA. 
Minor allele 
frequency 
Frequency at which the second most common allele occurs in a given 
population. (MAF) 
Missingness Degree of missing data from a set. 
Odds ratio How strongly the presence or absence of an allele associated with the 
presence or absence of disease in a given population. (OR) 
Pseudo autosomal 
region 
Regions of the X and Y chromosome that pair and recombine during 
meiosis. (PAR)  
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Term Definition 
Phasing Phasing, or haplotype estimation, refers to the statistical estimation of 
haplotypes from genotype data. 
Polymorphism Variations in DNA that originated during evolution as a result of mutations. 
Indicates that a locus has more than one form in the population. Should 
occur with a frequency of greater than 1% in the population to be classified 
as such. 
Population 
admixture  
The recent combination of two or more previously distinct populations. 
Unknown admixture may result in spurious genetic associations in a case-
control study design. 
Recombination  The rearrangement of genetic material, especially by crossing over in 
chromosomes or by the artificial joining of segments of DNA from different 
organisms. 
Sex The anatomy of an individual's reproductive system, and secondary sex 
characteristics. 
Sex-specific An effect that is localised to only one sex. 
Sex-stratified Splitting by sex and separating males and females. 
Single Nucleotide 
Polymorphism 
A variation type in DNA where a single nucleotide has more than one allele 
in a population. Coding SNPs are found in genes and non-coding SNPs 
are present in promoters, introns, or intergenic regions. Synonymous 
SNPs will not result in an amino acid change in the protein, while non-
synonymous SNPs will lead to a change of the amino acid at that position. 
(SNPs) 
SNP/Genotyping 
microarray 
Array technology that allows large numbers (up to a million) of SNPs to be 
genotyped on a single array typically the size of a microscope slide. 
True association Association with the true causal variant. Also known as direct association. 
X chromosome 
inactivation 
The process through which one X chromosome is inactivated in females. 
(XCI) 
X inactivation centre  Locus on the X chromosome responsible for regulating XCI. (XIC) 
X chromosome wide 
association study 
Similar to GWAS except that XWAS specifically targets the X chromosome 
genetic variants within GWAS data. (XWAS) 
 
1.2 Epidemiology of tuberculosis 
In 1993 the World Health Organisation (WHO) estimated that approximately 25% of the world’s 
population was latently infected with M. tuberculosis and declared TB a global health problem (26). 
While TB is the leading cause of death by a single infectious agent worldwide, the TB incidence has 
declined globally by approximately 1.4% between 2000 and 2016 (27). TB deaths have decreased by 
37% since the year 2000 and notification rates are slowly decreasing. While these are inspiring 
statistics, the incidence rate will need to reduce by a further 3-4% a year if the WHO goals for 
combating TB and reducing the number of deaths by 75% (compared to the 2015 death rate) are to 
be met by 2025 (27). While TB is mostly under control in developed countries it is still a serious 
problem for developing countries (28–30).  
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Figure 1.1: Global TB incidence rates for 2016 (27). 
South Africa has an extremely high TB burden at an incidence rate of 781 per 100 000 individuals 
(Figure 1.1) (27). The high TB prevalence in South Africa is further compounded by the high HIV 
prevalence (12.6%), since M. tuberculosis takes advantage of the compromised immune system of 
HIV positive individuals (31,32). Drug resistant TB, often the result of poor adherence to treatment, 
further exacerbates the disease burden. 
1.3 M. tuberculosis, transmission, infection and symptoms 
M. tuberculosis is a rod shaped, aerobic, non-spore forming, acid-fast bacilli, with a thick lipid cell wall 
(33). This thick lipid wall, consisting of mycolic acid (fatty acid) and arabinogalactan (peptidoglycan 
bound polysaccharide), acts as a barrier and a key component of M. tuberculosis success as it 
increases virulence and aids in developing drug resistance, evading the host immune response and 
surviving in macrophages (34).  
Spread of M. tuberculosis and transmission of the disease is due to small airborne droplet nuclei that 
contain viable bacteria (35). Sneezing, coughing or talking in close proximity can disperse these 
droplet nuclei from an infected individual to the surroundings (Figure 1.2) (36,37). Upon inhalation of 
these droplets the hosts cell mediated (innate) immune response is triggered to fend of the invading 
M. tuberculosis bacilli (38). Infection begins when the M. tuberculosis bacilli are phagocytosed by 
alveolar macrophages or dendritic cells, where they will either be destroyed or survive depending on 
the virulence of the infecting strain and the efficacy of the host immune response (Figure 1.2) (38,39). 
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Figure 1.2: Mechanisms by which TB is transmitted between individuals (40).  
Failure to kill the bacilli results in the formation of granulomas, a collection of macrophages, T and B 
lymphocytes and fibroblasts, forming a structure designed to stop the spread of the M. tuberculosis 
(Figure 1.2). Following formation of the granuloma the T-lymphocytes secrete cytokines to promote 
the killing of M. tuberculosis. Here the bacilli can be cleared, or if the immune system is unable to 
clear it the bacilli can enter a seemingly dormant state (latent infection) (38). However, if the immune 
system cannot control the infection, due to a compromised immune system as a result of HIV 
coinfection for example, then the bacteria will multiply and cause active disease.  
If the M. tuberculosis infection is contained in the lungs it is referred to as pulmonary TB (PTB), but 
the granulomas can also rupture (Figure 1.2), and the bacteria can spread to and infect other parts of 
the body resulting in extra pulmonary TB (EPTB). Symptoms of specifically PTB include chronic and 
persistent coughing, loss of appetite and weight, fever, night sweats and haemoptysis (41), while 
EPTB presents with a great variety of symptoms and is difficult to diagnose (42).  
1.4 Diagnosis and treatment 
Once an individual presents with TB symptoms quick and accurate diagnosis is vital for ensuring the 
best treatment outcome. Several techniques to diagnose active TB are available with varying degrees 
of sensitivity and accuracy (41). Sputum microscopy, liquid or solid media culturing, chest X-ray, 
histopathological biopsy, and nucleic acid amplification test are some examples. There are also more 
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rapid tests such as the GeneXpert assay that can detect M. tuberculosis in a sample and the updated 
version of the GeneXpert can even detect Rifampicin (RIF) resistant M. tuberculosis strains (43).  
Once diagnosed, an appropriate treatment regimen must be set in place which can last at least six 
months and can have serious side effects (44,45). The first line treatment against drug susceptible 
M. tuberculosis consists of a four-drug regime including INH, RIF, pyrazinamide and ethambutol and 
can have high cure rates (45,46). However, due to the long treatment time and side effects of the 
drugs, treatment adherence and completion is a serious problem which has led to the development 
of drug resistant M. tuberculosis (47).  
1.5 Tuberculosis is a complex disease  
Upon infection, progression to active TB depends on several factors including the strain of infecting 
M. tuberculosis, the host’s environment and behaviour and finally the genetic makeup of the host (48). 
An individual’s socio-economic standing can influence TB susceptibility, as individuals living in 
overcrowded conditions are more likely to contract TB (48). Nutrition is also important as inadequate 
nutrition can alter the immune response and increase risk of developing TB (49–51). Finally, multiple 
meta-analysis and systematic reviews show that smoking and alcohol consumption considerably 
increase TB susceptibility (52–57).  
While these behavioural and environmental factors do influence TB susceptibility there is also very 
clear evidence that host genetics play a significant role in TB susceptibility. The first piece of evidence 
is that only 5-10% of infected individuals globally develop active TB. An example supporting the 
genetic contribution is the 1926 Lϋbeck incident in Germany, where 251 new-borns were vaccinated 
with live M. tuberculosis instead of BCG. Of the new-borns seventy-seven died, 47 developed latent 
TB and 127 got sick but recovered (58). This event demonstrates how individual immune responses 
differ in efficacy, demonstrating the importance of host genetics which underlies the immune system.  
Several twin studies have also shown that monozygotic twins have higher concordance for the 
disease than dizygotic twins (59–61). Moreover, studies showed of adopted children showed that they 
were more likely to die from TB disease if their biological parents had died from it, clearly indicating a 
genetic component to TB susceptibility and that environmental factors are not the only influential 
factors (62–65). Population specific effects have been observed for disease susceptibility and are 
also indicators of the role of host genetics. Europeans have been challenged by TB since before the 
18th century and thus, through a process of natural selection, host genetic markers may have been 
selected that made the European population less susceptible to TB (64,66). Subsequently, when the 
Europeans brought TB to Africa through colonialization the bacteria were spread to African 
populations who had not been challenged by European TB strains before and thus had not built up 
any genetic resistance, making them more susceptible to TB (1,64,67,68).  
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Since the discovery that host genetics influences TB susceptibility several methods have been used 
to determine which genes or genetic loci are associated with disease susceptibility. These approaches 
included family and linkage studies to find areas of the genome that segregate more often in affected 
individuals compared to control individuals (69,70). Heritability analysis to determine if TB 
susceptibility is a heritable trait and which genetic loci are responsible for this have been conducted 
and suggest a clear heritable component in TB susceptibility (71–73). Animal studies have also been 
used to prove the genetic contribution to TB susceptibility and homologous susceptibility genes have 
been mapped in humans (6,74). Finally, a number of single nucleotide polymorphism (SNP)- based 
association studies have been conducted in the form of candidate gene association studies as well 
as genome wide association studies (GWAS) to identify SNPs and genes associated with TB 
susceptibility (1). 
1.6 Association studies 
The human genome consists of approximately 3.2 billion base pairs. Adenine (A), thymine (T), 
guanine (G) and cytosine (C) nucleotides are linked in a specific sequence, creating the blueprint for 
life. The vast majority of these genomic sites (99%) are identical with all humans carrying the same 
base residue at both chromosomal homologs (75). The remainder of the nucleotides can vary within 
the population and explain much of the diversity observed in humans. Approximately 10 to 15 million 
of these variable base residues or single SNPs have been identified in humans. SNPs are used as 
biological markers to detect genes that are associated with disease.(76,77).  
Initially, candidate gene association studies were done to correlate SNPs with a particular phenotype 
or disease (77). Based on prior knowledge of biology and pathogenicity of a disease, candidate genes 
were identified and SNPs within these genes were tested to determine their association with a specific 
trait or disease. While this is an attractive study design, candidate gene associations studies have 
had limited success, with results often not being replicated in independent studies and associations 
being generally weak (77). The biggest limitation of candidate studies is that they require prior 
knowledge of disease pathogenesis to identify genes of interest and thus require a hypothesis. 
However, this hypothesis is limited to one gene and does not consider the rest of the genome and its 
potential interaction with the gene of interest.  
Genome-wide association studies (GWAS) managed to bypass this limitation as advances in 
technology allowed for simultaneous genotyping of thousands of SNPs across the entire genome. 
This advantage of SNP microarrays meant that prior knowledge of gene or pathogen function was no 
longer required. Studies are thus not limited to the effect of just one gene and could analyse genome 
wide genetic contributions to a single trait or phenotype without a hypothesis, i.e. hypothesis free 
testing. This shift towards a hypothesis free data driven science allows for an unbiased analysis of 
the variation across the genome at a fraction of the time or cost of candidate gene studies (78).  
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The goal of GWAS is to detect associations between variants and traits in samples from the 
population, with the aim of understanding which genes are involved in a disease or will lead to 
improved treatment or preventative strategies (79). The potential for GWAS to succeed depends on 
various factors including how many loci affecting a certain trait segregate in the population, the sample 
size and power required to detect associations, the joint distribution of effect sizes and minor allele 
frequencies (MAF) of the SNPs and the panel of SNPs used to genotype the population (79). Correct 
phenotyping is also of vital importance as variations in the phenotype can introduce heterogeneity, 
which will reduce the power to detect informative associations and could lead to spurious results. 
In order to conduct informative GWAS studies SNP microarrays have been developed that can 
genotype between 100 000 and 2.5 million variants simultaneously. Furthermore, as even the densest 
genotyping array captures only a fraction of the variation in the human genome, SNP arrays were 
designed in such a way that SNPs not directly genotyped can be inferred based on the pattern of 
available genotypes (79). This process, called imputation, exploits the phenomenon of linkage 
disequilibrium (LD) and is based on the correlation between SNPs in the current human genome (79). 
This correlation is a result of historical evolutionary forces and when alleles at two or more loci appear 
together more often than would be expected by chance then these variants are said the be in LD (75). 
Two SNPs in high LD can thus serve as proxies for one another and due to the correlation, genotyping 
one can give almost complete info on the other SNPs genotype. 
LD patterns need to be elucidated by mathematically, quantifying them in fully sequenced or densely 
genotyped reference populations (75). By comparing regions of LD between an appropriate reference 
population and the study population missing genotypes can be inferred into the study data (80). This 
increases the number of variants available for testing in GWAS, which in turn increases the likelihood 
of detecting significant associations. Datasets for imputation are now widely available and represent 
a diverse set of populations with dense genotyping, perfectly suited for imputation.  
These reference datasets include amongst others, the 1000 Genomes phase 3 data (1000G) (81), 
the Human Genome Diversity Project (82), Haplotype Reference Consortium (HRC) (83) and the 
HapMap consortium (84). These reference datasets at first, as with the SNP arrays, were tailored for 
European populations making them less than ideal for studying or imputing more diverse or admixed 
populations like Africans, Hispanics, or in our case the 5-way admixed South African Coloured (SAC) 
population (85–87). More recently however increased number of individuals from more diverse 
populations were added to current reference datasets and additional databases were also initiated 
that focused more specifically on African populations, which were greatly underrepresented. The 
Consortium on Asthma among African ancestry populations in the Americas (CAAPA) (88), the 
African Genome variation project (AGVP) (89) and the African Genome Resource1 (AGR, not publicly 
                                               
1 https://imputation.sanger.ac.uk/ 
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available) are three resources which have recently become a viable option for accurate imputation of 
African populations.  
Another advantage of LD and imputation is that it allows us to conduct meta-analysis by maximising 
the SNP overlap between different GWAS datasets (90). Many of the available SNP arrays genotype 
for different markers and at varying density across the genome and thus overlap between different 
genotyping platforms can vary significantly (91). Meta-analysis increases the power to detect 
associations by increasing the sample size through the combination of different studies on the same 
trait or disease (77). By increasing the number of samples and overlapping variants, the power of 
meta-analysis is further amplified and can allow for identification of population specific and globally 
associated variants.  
However, LD and imputation does have its drawbacks. Increasing the number of variants increases 
the multiple test correction burden. By adjusting the significance threshold based on the number of 
independent tests performed, the number of false positive associations can be controlled (92). This 
multiple testing burden can be further compounded by small sample sizes and low power, making it 
impossible to detect small effects or link rare variants with a trait or disease. Furthermore, due to LD, 
spurious associations can survive multiple test correction if the associated variant is not actually the 
causal one, but merely linked to the causal variant (75). This is especially true for rare variants, which 
are often in LD with other non-causal rare variants and a single causative rare locus could be linked 
with multiple false positive associations (93). Teasing out which of the two variants in LD is the actual 
causal variant is a process called fine mapping and can be very difficult to determine through GWAS 
alone (93). To resolve this, further investigation is required in a population with lower LD, in which the 
causal variant might be identified, or functional studies can be conducted on the effect of the variant 
in vitro or in vivo (94). 
The effects of LD and sample size are two of the limitations of GWAS. Other limitations include 
statistical and computational issues e.g. analysing and storing large amounts of data (75,76). As the 
number of markers on the array increased so did the statistical challenge of analysing them. Also, 
many traits or phenotypes are polygenic and associated with many alleles of small effects that 
collectively contribute to the phenotype (93). Furthermore, there are also interactions between 
different loci in the genome (epistasis) and between genes and the environment, both of which can 
influence the power of a GWAS (77).  
The design of SNP arrays also requires prior knowledge of the genome in order to choose the most 
informative markers for genotyping (95). Knowledge of these markers was limited when GWAS were 
introduced and could have, at least initially, limited the applicability of chosen markers. While these 
limitations were daunting, instead of limiting SNP microarray technologies they instead spurred 
advances in other areas of research. New computational and statistical methods were developed to 
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clean and analyse these large datasets. For example, the concept of determining false discovery rate 
(FDR) was introduced in order to lower the impact of conventional multiple test correction and 
methods to determine how accurate statistical testing was were also introduced in the form of quantile-
quantile (QQ) plots and Manhattan plots (93).  
Improved analysis techniques also led to an increased number of SNPs associated with a certain trait 
or disease, which in turn led to research to understand the link between these variants and the 
phenotypic effect. Elucidating biological functions allowed for more relevant markers to be added to 
SNP arrays resulting in a cycle of progress where progress in one field (SNP arrays) fuelled progress 
in the other two (computational methods and biological understanding), resulting in advances that 
would not have been possible independently (75). By dealing with these limitations instead of 
succumbing to them, GWAS has found many applications in many research areas and contexts and 
experienced great success over the past decade. GWAS has mapped causal variants (96), LD 
patterns (97), introduced phasing (98) and inferred demography, ancestry and evolution (85,99–103). 
Despite these successes there is one area of research where GWAS has made a significant impact 
but has not yet delivered what was expected of it and that is the analysis of complex diseases. 
Complex diseases are acquired diseases where susceptibility depends on both the environment, 
behaviour and hereditary factors and does not follow a classic pattern of inheritance (77). Instead 
complex disease susceptibility is more likely a result of a combined effect of many common variants 
with small effects sizes (polygenic) as well as environmental factors and gene-gene interactions 
(77,93). Omnigenic effects could also influence susceptibility to complex diseases, but the omnigenic 
model has not been fully explored and there are some concerns regarding its validity and thus it will 
not be considered here (104,105). While the environment and behaviour play a large role, there is a 
proven genetic component in many complex diseases and by choosing samples carefully (in the case 
of a case control association study) the environmental and behavioural impact can be controlled for, 
allowing us to focus on the genetic factor.  
Sample size and multiple test correction is perhaps the largest stumbling block for GWAS in complex 
diseases as multiple genes with small effects will require tremendous power to identify and could be 
lost due to multiple test correction. Increasing the sample size through conducting meta-analysis 
would thus greatly benefit the analysis of complex diseases by increasing the power. Furthermore, 
many genes identified in GWAS for complex diseases have no known biological effect, due to 
incomplete knowledge of gene function and thus their role in disease susceptibility cannot be 
elucidated (77). Despite these limitations GWAS in complex diseases, such as inflammatory bowel 
disease, diabetes and Alzheimers, have successfully identified novel pathogenic mechanisms and 
therapeutic targets (106,107). 
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Another area of success of GWAS in complex disorders and traits is its relationship to the concept of 
missing heritability. Heritability is the proportion of phenotypic variance that can be explained by 
genetic variance and missing heritability is thus observed heritability that is not, or not yet explained 
by genetic variance (108). GWAS for height and susceptibility to schizophrenia for example elucidated 
a great portion of the missing heritability. In 2009, 40 SNPs were significantly associated with height 
explaining 5% of heritability, by 2014 the number of significant associations increased to roughly 700 
SNPs, explaining about 20% of heritability (109,110). Similarly, the number of variants significantly 
associated with schizophrenia increased from one SNP in 2009 to 108 SNPs in 2014 (111,112). 
Elucidating the missing heritability and identifying all loci that contribute towards it, is both a function 
of genome coverage (how much genetic diversity can be captured) and sample size. As the sample 
size and genomic coverage of arrays increases more and more variants will be identified explaining 
an ever-increasing amount of the missing heritability, but as the effects of these variants are likely to 
get smaller the sample sizes will constantly need to increase in order to capture all variation in the 
genome (79). Here imputation and meta-analysis can be of great benefit to increase the genomic 
coverage and sample size and power to detect associations in order to fully elucidate complex 
diseases.  
1.7 GWAS and the X chromosome 
Since the introduction of GWAS, the sample sizes have been steadily increasing and so is the amount 
of data available for imputation and meta-analysis. The computational methods and statistics to deal 
with this ever-increasing amount of data has also improved over time allowing for better quality and 
more informative analysis. However, one aspect of GWAS and its influence on traits, phenotypes and 
diseases has until very recently been ignored: the analysis of the X chromosome and the impact of 
X-linked genes on a trait or disease and its potential contribution to the missing heritability (113).  
Most genotyping array contain probes for X-linked variants, making this data readily available, yet it 
has been consistently excluded from most GWAS for several reasons. Firstly, compared to the 
autosome the X chromosome has fewer markers and suffers from lower genotyping accuracy. 
Secondly, X-linked variants are unique as they are diploid for females and haploid for males, which 
pose a statistical challenge. Comparing or combining diploid and haploid markers for association 
analysis is challenging and certain statistical techniques, such as the Hardy–Weinberg equilibrium 
testing (HWE), cannot be calculated for haploid loci (113). This means that analysing X chromosome 
genotyping data cannot be done in the same way that autosomal genotyping data is analysed.  
The X chromosome requires separate quality control and analysing in a sex-stratified manner 
(114,115). Stratifying the data by sex pose a problem as it reduces the sample size and thus power 
to detect associations. This, combined with the fact that male haploid genotypes further lower the 
power and the number of X-linked markers is low, means that many studies are not powerful enough 
Stellenbosch University  https://scholar.sun.ac.za
12 
 
to detect X-linked loci (113). Also, the special analysis techniques required might be too daunting for 
researches with limited specialised knowledge in bioinformatics and statistics, requiring someone with 
expertise in these fields. This statistical complexity is further compounded by the fact that in females 
one X chromosome is randomly inactivated in each cell of the body to equalise dosage of gene 
expression between males and females. This process of X chromosome inactivation (XCI) and 
associated processes such as genes that escape inactivation and skewed inactivation will further 
influence phenotype and complexity of X-linked analysis, especially as the processes of XCI are not 
yet fully understood (113,116,117). 
Although the X chromosome has been ignored in the past due to its statistical and biological 
complexity it is clearly involved in diseases susceptibility. The Online Mendelian inheritance in man 
(OMIM) catalogue of human genes and genetic disorders suggests that about 7% of phenotypes with 
known molecular basis (autoimmune disorders, cognitive and behavioural conditions) are caused by 
X-linked genes (113). Furthermore, the X chromosome contains approximately 5% of the genes in 
human genome, and many of these have been shown to be involved in the immune function 
(118,119). The X chromosome also contains the highest density of regulatory miRNA molecules, 
providing further evidence for the involvement of the X chromosome in biological functions and 
possibly disease susceptibility (118).  
Even though evidence for the involvement of the X chromosome in immune functions is strong and 
tools to impute and analyse X-linked variants have improved it is still being ignored in most GWAS 
studies (114,115,120,121). This is evident when looking at the records of published GWAS. To date 
there are 3420 publications, in which 62652 unique SNP-trait associations have been identified are 
recorded in the online GWAS catalogue2. Of these associations only 385 SNPs (0.6%) were X-linked 
and only 157 (0.25%) of them reached genome wide significance ( p-value < 5e−8) (122). This 
highlights the extent to which the X chromosome has been ignored in the past and it is vital for this to 
change.  
If most of the GWAS published to date had X chromosome data but excluded it from analysis, then 
there is a tremendous amount of unexplored data that is already available for analysis. As tools to 
analyse the X chromosome are now available there is no reason not to explore it. Only by starting to 
include the X chromosome in GWAS analysis will its impact on immune functions and sex-bias be 
elucidated. Identifying novel X-linked variants will spur research and advances in functional 
annotation of X-linked genes, increasing understanding of biological function and thus enable us to 
increase coverage of X chromosomal markers on SNP arrays. As use of X-linked analysis tools 
increase they too will improve resulting in improved data which could elucidate sex specific immune 
responses and explain a portion of missing heritability (113). Analysis of the involvement of the X 
                                               
2 https://www.ebi.ac.uk/gwas/  
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chromosome is especially important for complex diseases that present with a strong sex-bias, such 
as TB, discussed below.  
1.8 Tuberculosis and the X chromosome 
Tuberculosis presents with a strong male sex-bias and globally the incidence rate is nearly twice as 
high in males compared to females (Figure 1.3) (27). Yet, while multiple candidate gene association 
studies and GWAS have been done for TB susceptibility in diverse populations, none specifically 
investigated the X chromosome or any alternative cause for the sex-bias (72,85,123–131). Some 
candidate gene studies have identified X-linked genes associated with TB susceptibility such as Toll-
like receptor 8 (TLR8) and some GWAS studies analysed X-linked variants (96,123,126,132–138). 
The fact that females have a more robust immune response towards infections indicates that X-linked 
variants could easily influence this male bias (139–141). 
 
Figure 1.3: Worldwide male to female ratios of TB incidence for children under the age of 14 (A) 
and children and adults over the age of 14 (B). World map image obtained from the R packages 
‘rworldmap’ and ‘rworldxtra’ and the data was obtained from the 2017 WHO TB report (27,142).  
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Figure 1.3A shows TB incidences in children under the age of 14 (pre-pubertal) for 29 high burden 
countries as well as the European Union and the United States of America. While incidence rates in 
some countries were the same between males and females, most have a slight male bias and no 
country had a female bias for incidence rates in young children (Figure 1.3A). Comparing these 
incidence rates to those from individuals over the age of 14 (Figure 1.3B) results in a clear increase 
in the male sex-bias across all countries, even those that initially had equal incidence rates between 
the sexes (Figure 1.3B).  
Since the male bias is present before puberty, but then significantly increases with age (Figure 1.3), 
indicates that sex hormones are likely to have a definite impact on this sex-bias. Furthermore, the fact 
that this male sex-bias presents globally (Figure 1.3) suggests that the bias can also not be fully 
explained by environmental, behavioural and socioeconomic factors or the strain of M. tuberculosis, 
although they do influence the sex-bias (140,143,144).  
Another influential factor in TB susceptibility is the influence of population specific effects (99,145). 
The effect of ethnicity is especially important when considering admixed populations as not correcting 
for ancestral components in statistical analysis can confound results (99,138). Furthermore, 
admixture events can be sex-biased with respect to the male to female ratio of founder contributions 
and this sex-bias in admixture leads to different ancestral distribution on the autosome compared to 
the X chromosome (146,147). These differences in ancestral distribution could further influence the 
sex-bias of TB disease through population specific effects amplified by certain ancestral components 
on the X chromosome of admixed individuals.  
Based on the evidence that the X chromosome and X-linked genes are involved in TB susceptibility 
and potentially influence the male bias it presents with, which could be further amplified by sex-bias 
admixture events, leads us to hypothesise that: 
• X-linked genes and their genetic interactions and functional mechanisms will elucidate the sex-
bias of TB disease, which could be further compounded by sex-biased admixture events.  
- Aims and Objectives: 
1. Test for the presence of sex-biased admixture in the SAC population. 
i. Infer global ancestry on the autosome and X chromosome separately and 
test for significant differences in their distribution. 
ii. Compare to previous results to confirm the viability of using global 
admixture components to infer sex-biased admixture.  
2. To identify TB susceptibility loci responsible for the sex-bias observed in TB 
susceptibility by conducting a TB GWAS and meta-analysis including data from 
multiple ethnic backgrounds.  
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i. Do association testing of the X chromosome in all the individual TB 
GWAS datasets 
ii. Determine the accuracy and optimise imputation in the admixed SAC 
population. 
iii. Impute X chromosome genotypes in all available TB GWAS data. 
iv. Perform a trans-ethnic X chromosome, TB meta-analysis to determine 
sex specific and/or combined effects 
3. Investigate gene-gene interaction to determine how X-linked genes interact with 
each other and the rest of the genome.  
i. Carry out a genome-wide epistatic analysis (gene-gene interactions) on 
the SAC data 
1.9 Structure of thesis  
Each chapter for this thesis is structured for potential publication. All chapters are in the format of a 
journal article, but whether submitted for publication or not, they have been edited to have the same 
format and referencing style (Vancouver) for the sake of consistency throughout this thesis. 
Supplementary material was inserted at the end of the respective chapters and one overall 
bibliography is given at the end of the thesis.  
Chapter 2: The X chromosome and sex-specific effects in infectious disease susceptibility. 
This review sets the tone for the thesis and highlights the involvement and importance of the X 
chromosome in immune functions and potential impact on sex-bias of infectious diseases, specifically 
TB. This review has been submitted to the journal of Human Genomics and is currently under review.  
Chapter 3: Autosomal and X chromosome markers confirm strong sex-biased admixture in the 
South African Coloured population. 
This paper proves that global ancestry inference on the autosome and X chromosome can be 
accurately determined and used to infer presence of sex-bias in the SAC population. 
Chapter 4: A sex-stratified genome-wide association study of tuberculosis using a multi-ethnic 
genotyping array. 
This TB GWAS in the SAC population is the first GWAS to conduct not only X chromosome specific 
analysis, but also sex stratified tests on the autosome. This chapter also reports on the first genome 
wide epistatic analysis performed for a TB susceptibility study. Results for this chapter indicate strong 
sex specific effects, highlighting the need for sex stratified and X-linked analysis. This chapter has 
been submitted to the journal Frontiers in Genetics and is currently under review 
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Chapter 5: Evaluating the accuracy of imputation in the 5-way admixed South African Coloured 
population. 
This methodological paper assesses the accuracy and aims to maximise the quality of imputation in 
the 5-way admixed SAC population on both the autosome and X chromosome.  
Chapter 6: X-linked trans-ethnic meta-analysis reveals Tuberculosis susceptibility variants 
This chapter reports on the first ever X chromosome specific trans-ethnic meta-analysis for TB to 
identify global and population specific X-linked susceptibility loci.  
.
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2.1 Abstract 
The X chromosome and X-linked variants have largely been ignored in genome-wide and candidate 
association studies of infectious diseases due to the complexity of statistical analysis of the X 
chromosome. This exclusion is significant, since the X chromosome contains a high density of 
immune-related genes and regulatory elements that are extensively involved in both the innate and 
adaptive immune responses. Many diseases present with a clear sex bias and, apart from the 
influence of sex hormones and socioeconomic and behavioural factors, the X chromosome, X-linked 
genes and X chromosome inactivation mechanisms contribute to this difference. Females are 
functional mosaics for X-linked genes due to X chromosome inactivation and this, combined with other 
X chromosome inactivation mechanisms such as genes that escape silencing and skewed 
inactivation, could contribute to an immunological advantage for females in many infections. In this 
review we discuss the involvement of the X chromosome and X-inactivation in immunity and address 
its role in sexual dimorphism of infectious diseases using tuberculosis susceptibility as an example, 
in which male sex bias is clear, yet not fully explored.  
2.2 Key words 
Tuberculosis, Sex-bias, X chromosome, Host genetics, Susceptibility  
2.3 Introduction 
The human sex chromosomes are genomic structures that distinguish males and females on the 
chromosomal level. The XY sex-determination system is present in humans and females have two X 
chromosomes, while males have one Y and one X chromosome (148). These chromosomes evolved 
approximately 180 million years ago from ordinary autosomes (149). Recombination during male 
meiosis was suppressed and over time, resulting in vast levels of divergence between the human sex 
chromosomes, with the exception of the pseudoautosomal regions (PAR1 and PAR2) located at the 
termini of the X and Y chromosomes (150). Over 800 protein coding and 600 non-coding genes are 
distributed over the nearly 155 million base pairs of the X chromosome (151). Until recently the X 
chromosome has largely been excluded from candidate gene and genome-wide association studies 
(GWAS) due to the statistical complexity of analysing and comparing the haploid male to diploid 
female data, but analysis tools have now been developed to incorporate this chromosome.  
Gao et al. (115) developed a toolset for X chromosome data analysis and association studies that 
can be used for quality control and analysis of X chromosome GWAS data. Other software using 
genotyping data, but not specifically focused on the X chromosome, have also included the option to 
analyse X-linked genotypes. PLINK version 1.9, a software to conduct association testing using 
genotyping data incorporated different models to analyse the X chromosome (120). Impute2 and 
shapeit2 are programs designed to impute and phase genotyping data respectively and until recently 
imputation and phasing was not possible for the X chromosome thus excluding this chromosome from 
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downstream analyses(152,153). The ability to increase the amount of genotyping data through 
imputation and including the X chromosome in statistical analysis allows for X-linked meta-analysis 
and could help elucidate sexual dimorphism. Admixture analysis uses an individual’s genomic data 
to determine ancestry by comparing allele frequencies to those of reference populations. Until recently 
this analysis was inaccurate for haploid genotypes and thus overestimated X-linked ancestral 
components in males. However, inclusion of haploid specific ancestry inference in the ADMIXTURE 
v1.3.0 software now allows for X-linked global ancestry inference (154). These ancestral components 
can now be included as covariates in X-linked association testing to improve the quality of the results. 
The software RFMIX also incorporated the option of assigning local ancestry on the X chromosome 
(155), allowing the comparison of autosomal and X-linked ancestral distributions, which could be 
indicate sex-biased admixture (156–158). 
The development of these tools is especially significant for diseases in which a sex bias is present.  
Human males are more susceptible to many diseases, including bacterial infections, while females 
are more likely to develop autoimmunity (140). This sex bias is not only due to socioeconomic and 
behavioural factors, such as the underreporting of female cases and/or access to healthcare, but may 
also in part be due to biological sex differences as determined by the X chromosome and X 
chromosome inactivation (XCI) (159). XCI is the process through which one X chromosome is 
inactivated to balance dosage of gene expression between XX females and XY males. XCI is 
established early during embryonic development and is maintained almost indefinitely. As males are 
haploid for the X chromosome it has been suggested that any damaging genetic variants on the X 
chromosome will have a more pronounced immunological consequence in males than in females, 
thereby introducing sex-based differences and influencing the sex bias of a disease. In contrast, 
females, who are functional mosaics for X-linked genes, may have less severe consequences, further 
compounded by the process of skewed XCI and genes escaping silencing (160). This review will 
focus on the involvement of the X chromosome and XCI in immunity and will address sexual 
dimorphism in infectious diseases using tuberculosis (TB) susceptibility as an example, in which sex 
bias is clear, yet not fully explored. 
2.4 X-chromosome, the immune system and sex hormones 
Many X-linked genes are involved in the innate and adaptive immune system (161). This includes 
pattern recognition receptors (PRRs) such as toll-like receptor (TLR7) and TLR8 as well as IRAK1, a 
key regulatory molecule in the TLR dependent signalling pathway (162). A number of transcriptional 
and translational control effectors functioning downstream of activated cytokine receptors are also 
located on the X chromosome (144). For example, NF-kB essential modulator (NEMO) modulates 
NF-kB expression, a transcription regulator that is involved in multiple immune pathways (163). 
Furthermore, it is not only X-linked genes that could influence the sex bias, but also X-linked control 
mechanisms like non-coding micro RNA (miRNA). The X chromosome contains approximately 10% 
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of the total genomic miRNA (164), which is involved in the regulation of gene expression by 
supressing mRNA translation or triggering mRNA degradation. Locations of immune related genes 
and key miRNA regions are indicated in Figure 2.1.   
 
Figure 2.1: Illustration of the X chromosome indicating the five different strata and chances of genes 
escaping inactivation within each stratum. Regions lined in red contains the highest densities of 
immune associated genes while genes discussed in this review are indicated in green. Genes that 
contain intragenic miRNA are indicated in black followed by the miRNA number. XIC: X chromosome 
inactivation centre containing XIST, XACT genes; PAR: pseudoautosomal region; TLR8: Toll-like 
receptor 8; TLR7: Toll-like receptor 7; CYBB: cytochrome b-245, beta polypeptide; AR: Androgen 
receptor; CXCR3: C-X-C motif chemokine receptor 3; TNFS5: encodes CD40 ligand; NEMO: NF-kB 
essential modulator; IRAK1: Interleukin-1 receptor associated kinase 1; HUWE1: HECT, UBA & WWE 
domain containing 1; GABRA3: Gamma-aminobutyric acid A receptor subunit alpha 3. 
The androgen receptor, a sex hormone receptor that inhibits antibody production is also coded on the 
X chromosome, showing that even the effect of sex hormones can be amplified by the X-linked sex 
hormone receptor genes (144). Sex hormones are involved in the immune response, and multiple 
immune related cells, including T-cells, B-cells, natural killer cells, macrophages and dendritic cells 
express estrogen receptors (ER-alpha and ER-beta), indicating that immune related cells are partly 
controlled by the female sex steroid hormone estrogen (144,165,166). In humans it is evident that 
females have increased resistance against microbial infections, which suggests that females have a 
more vigorous immune defence against most invading pathogens (167–170). Females also have 
higher antibody responses and more adverse reactions in response to a number of vaccines (144).  
Estrogen acts as an immune activator while testosterone acts as an immune suppressor (144,171). 
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Testosterone has been shown to have an inhibitory effect on the immune system through upregulation 
of anti-inflammatory cytokines (IL-10), while estrogen enhances the immune system by upregulating 
pro-inflammatory cytokines (TNFα) (172). In line with these hormone functions, it has been observed 
that for some diseases the male bias becomes apparent only after sexual maturation (ages 15-16 
years) and female progression to disease and mortality rates are altered during their reproductive 
years (173). However, sex-based differences in immune responses exist between pre-pubertal girls 
and boys as well as post-menopausal women and elderly men, indicating that sex bias is present 
without the involvement of hormones (144). These differences could be attributed to the complexity 
of studying the impact of hormones on disease susceptibility while using different experimental 
designs between studies (140).  Sex hormones also vary with age and physiological state of the 
individual and can regulate transcription of many genes involved in the development and maturation 
of immune cells. They also influence the regulation and modulation of the immune response and 
immune signalling pathways (174). Although both sex-hormones and the X chromosome affect the 
immune system, the effects of these two factors are likely independent of each other (140).  
2.5 X chromosome inactivation 
Females carry both a maternal and paternal X chromosome, while males carry only a maternal copy. 
In order to regulate dosage expression of X-linked genes, one X chromosome is inactivated in 
females, resulting in them being functional mosaics for X-linked genes (164). XCI is initiated in early 
fetal development and either the maternal or paternal X chromosome is randomly silenced in XX cells. 
This is maintained through epigenetic mechanisms in subsequent cellular divisions to ensure 
balanced expression X-linked genes in females (175).  
XCI developed as a response to gene loss in the Y chromosome during the evolutionary development 
of the human sex chromosomes (150). Mammalian sex chromosomes developed from a pair of 
autosomes approximately 300 myr ago (176). Several large-scale chromosomal inversions on the Y 
chromosome led to disruption of homology between the sex chromosomes, suppressing 
recombination and resulting in Y chromosomal gene loss in the inverted chromosomal region (150). 
These inversions on the Y chromosome are referred to as strata as indicated in figure 1. Following 
gene loss on the Y chromosome X-linked gene expression needed to be increased in males to control 
the dosage of gene expression from the single X chromosome. In female’s upregulation of X-linked 
genes would disrupt dosage compensation as they have two X chromosomes and as a result one X 
chromosome is inactivated. However gene expression is upregulated on the active X chromosome in 
order to regulate dosage (177,178). XCI is a vital mechanism in females as many X-linked genes are 
extremely dosage sensitive and any disruption of the dosage compensation mechanism could have 
severe developmental and health consequences (177).  
Mary Lyon first proposed the XCI hypothesis based on her observations in mice (179) and since then 
significant progress has been made in elucidating the XCI mechanism in mice. The XCI mechanism 
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in humans is still unclear and beyond the scope of this review but discussed elsewhere 
(177,180,181,181–186). Briefly human XCI is thought to be controlled by the X inactivation centre 
(XIC), an X-linked locus located at Xq13 (Figure 2.1) and containing multiple protein and RNA coding 
genes potentially involved in the XCI mechanism (187). The two main long noncoding RNAs identified 
thus far are the X-inactivation specific transcript (XIST), responsible for silencing and the X active 
specific transcript (XACT) which keeps the X chromosome active (188–191). The exact mechanisms 
of how these lncRNAs determine the state of a X chromosome is still unclear and it has also been 
proposed that a third regulatory element, potentially coded by a gene on chromosome 19 is also 
involved in the XCI process (177). Hypotheses about the lncRNAs as well as an autosomal regulatory 
element are discussed in detail elsewhere (177,187,192–195). While the exact mechanisms are 
unclear, the importance of these lncRNAs have been validated as SNPs or mutations in the XIC can 
have severe effects on XCI, by disrupting dosage compensation, which could impact on female 
development and health (177,196). In fact, evidence of the effect of XCI can be seen in tumorigenesis 
and noncongenital diseases, where loss of XCI control has led to tissue instability and decreased 
defence against diseases (139,197,198), including autoimmune diseases (199). 
While disruption of XCI could be detrimental to females as it disrupts dosage compensation, the 
mosaic nature as a result of XCI could give them a distinct advantage over males (140,181). 
Deleterious X-linked mutations have large effects and could lead to death or disease in males due to 
them being haploid for X-linked genes. In females however, random inactivation leads to a mosaic 
makeup where about half of the cell population expresses the mutant allele while the other half 
expresses the wild type allele. This heterozygous expression means the wild type allele can 
compensate for the mutant allele and lessen the impact or penetrance of this allele in females 
compared to males (177). This mosaic advantage in heterozygous females can be further 
compounded by non-random or skewed inactivation and genes that escape silencing.   
2.6 Escaping X inactivation and skewed or non-random inactivation 
While the XCI process in humans is not yet fully understood, studies of human aneuploidy indicate 
that in a diploid human cell there is always just one active X chromosome in either sex (177,181). In 
Turner syndrome individuals have only one sex chromosome (one X chromosome, X0) which is kept 
active, while in males with Klinefelter syndrome (XXY) one X chromosome is silenced (177). This 
suggests that the human XCI mechanisms protects one X chromosome while inactivating all others.  
However, some X-linked genes have Y homologs (most of them situated on the distal end of Xp and 
PAR regions) and thus two copies are present in males and females. To maintain dosage balance 
between the sexes these XY genes escape silencing. Most genes that escape silencing are located 
in the Xp region and are often depleted in repressive marks associated with XCI and enriched for 
markers associated with active gene transcription (200). These regions that escape inactivation carry 
features associated with active chromatin (201). This suggests that genes that escape silencing are 
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subjected to a regional bias, which correlates with the theory that distal genes in younger strata 
(regions on the X chromosome that differentiated from the Y chromosome last and contain more XY 
genes than older strata) have a higher chance of escaping inactivation.  
More recent evidence extrapolated on the idea of regional bias in escape from inactivation and 
showed that the chance of genes escaping silencing is also dependent on a gene to gene specific 
bias (176). This is supported by the fact that approximately 15-20 % of X-linked genes outside of PAR 
also escape silencing even though they are subject to less regional bias. Naqvi et al. (176) classified 
X-linked genes into 3 classes, namely X-linked genes with a surviving homolog (class 1) and X-linked 
genes without a surviving homolog that are either subject to XCI (class 2) or escape silencing (class 
3) (176). These three classes of X-linked genes differ based on dosage sensitivities. Class 1 genes 
were most dosage sensitive and expression required strict regulation, while class 2 genes had 
intermediate dosage sensitivity while class 3 genes that escaped silencing had the lowest dosage 
sensitivity (176). This suggests that genes that escape silencing are subjected to regional bias and 
the chance of escape depends on the sensitivity of that gene to changes in dosage. While defects in 
the XCI mechanism could disrupt the XCI pattern of dosage sensitive genes and be detrimental to the 
health and development of females, genes that are less sensitive to dosage could escape resulting 
in altered gene expression between the sexes and potentially contribute towards a sex-specific 
phenotype, which could contribute to sex biases in disease susceptibility (140,161,202).  
Random inactivation ideally leads to a balanced mosaic of X-linked genes in females. However, this 
balance can be disrupted, especially in heterozygous females carrying deleterious mutations on one 
or both X chromosomes, or if the XCI mechanism is defective, leading to a skewed inactivation 
pattern. Skewed inactivation is the process by which one X chromosome is preferentially silenced in 
over 75% of cells. If a cell has a deleterious mutation on the active X chromosome it could alter the 
viability of the cell and even lead to cell death, suggesting that these mutations could lead to positive 
or negative selection of a specific active X chromosome (203,204). The extent of this selection 
pressure is correlated with three factors. Firstly, the viability of the cell which will be determined by 
the active X chromosome. If cells with an active X chromosome with a detrimental gene die, then only 
cells with the viable gene will propagate. This depends on the type of mutation (synonymous or non-
synonymous) and its effect on gene function. Second, the gene function can influence the skewing if 
it is tissue-specific while a constitutively expressed gene could affect the skewing on a global scale. 
Finally, genes escaping inactivation can also influence selection as they will influence the penetrance 
of the mutated gene (205). While cell viability combined with XCI can skew inactivation patterns, other 
aspects can also lead to non-random inactivation. Defects in the XCI mechanism can also lead to 
skewed inactivation and SNPs in the XIST gene correlates with skewing. Plenge et al. (196) showed 
that skewed inactivation profiles in multiple females occurred due to a C to G transversion in the 
promoter region of the XIST gene (196). However, some females with this transversion still had nearly 
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random inactivation suggesting that the transversion alone is not enough to skew inactivation and 
some other defect compounding the effects is likely present as well.  
Other factors that can result in skewed inactivation is reduced number of embryonic cells at the onset 
of XCI and age. The lower the number of cells at the onset of XCI the higher the chance of observing 
non-random inactivation and any bottleneck during development that limits the number of cells can 
lead to skewed inactivation (205). Age has also been correlated with degree of skewing which seems 
to increase in older women (206–209). The exact reason why skewing increases with age is unclear, 
but it could be as a result of stochastic loss and genetic selection of subtle SNPs, gradually increasing 
their penetrance over time due to increased skewing in the XCI pattern (206,207,210,211). The 
causes of skewed XCI discussed here suggest that this process is genetically determined (203) and 
can give females an advantage by protecting them from deleterious mutations and their effects. 
However, skewed inactivation patterns have also been observed in numerous tumours and cancer 
types (200,212). This suggests that the combined impact of XCI, genes that escape silencing and 
skewing can lead to sex-specific phenotypes and potentially affect disease and developmental bias 
between the sexes.  
2.7 X chromosome and infectious disease susceptibility 
It is well documented that females have a stronger innate and humoral immune response than males 
and are thus less susceptible to many bacterial, fungal, parasitic and viral infections, while being more 
prone to developing an autoimmune disease or malignancies (Table 2.1, (168)). However as not every 
microorganism elicits a sex-differentiated response it has been proposed that the invading organisms 
and how they interact with the host are important contributing factors to whether or not the host 
immune response will differ between the sexes (213).  
Table 2.1: Sex bias of selected bacterial, fungal, parasitic and viral infections. 
Infection Organism Disease Bias Reference 
Bacterial Treponema pallidum syphilis male (214–216) 
Borrelia burgdorferi Lyme disease Male (age) (217,218) 
Vibrio vulnificus Infection Male (219) 
Staphylococcus aureus Infection Male (220,221) 
Pseudomonas 
aeruginosa 
Infection Male (220,221) 
Escherichia coli Bacteraemias Female (220,221) 
Fungal Cryptococcus 
neoformans 
fungal meningitis Male (222–224) 
Candida albicans onychomycosis Female (225–230) 
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Infection Organism Disease Bias Reference 
Paracoccidioidal 
brasiliensis 
Infect mucosal 
membranes 
Male (231) 
Parasitic Schistosoma Schistosomiasis Male (232–234) 
Leishmania Leishmaniasis Male (232–234) 
Taenia Tapeworm Female (232–234) 
Viral Influenza A Influenza Male (141,235–
237) 
Hepatitis C Hepatitis Male (238,239) 
 
Many infections exhibit sex biased incidence rates and many of them present with a male bias (Table 
2.1). While age and sex hormones contribute, as in the case of Lyme disease and Hepatitis, these 
factors do not fully account for this (217,218,238,239). This suggests that the X chromosome and XCI 
may contribute to this bias. Supporting evidence from this can be taken from the mouse four core 
genotype (FCG) model. In this model the sex chromosome complement of the mice (XX or XY) does 
not relate to the gonadal sex, allowing for both XX males and females as well as XY males and 
females (240). This allows the study of the phenotypic effect based on sex complement, with and 
without the influence of sex hormones. Studies using the FCG model have identified differences in 
behaviour, gene expression, disease susceptibility that were solely due to sex chromosome 
complement and independent of sex hormones (240).  
While the FCG is only a model it can still provide useful information and shows that sex chromosome 
complements, X-linked genes and XCI can severely impact sex-differences in phenotype. Recent 
studies in female T and B cells could explain the enhanced female immune response to infection. XCI 
in female lymphocytes is predisposed to become partially reactivated, allowing genes to escape 
silencing leading to overexpression of immune related genes (193,241). Female T-cells had biallelic 
expression of CD40LG, CXCR3 and TLR7. The same was observed for B-cells where biallelic 
expression and increased transcription of X-linked immune-related genes was observed (241). 
Furthermore, in both T and B-cells the XIST RNA pattern was dispersed and the inactivated X 
chromosome lacked typical heterochromatic modifications usually associated with the inactive X 
chromosome (241).  
These studies in female lymphocytes provide mechanistic evidence for enhanced female immunity to 
infectious diseases and the involvement of X-linked genes and XCI. The enhanced immune response 
and increased expression of immune related genes could also explain why females are more prone 
to developing autoimmune disorders (140,168,241,242).    
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2.8 X chromosome and tuberculosis 
TB, caused by the bacterium Mycobacterium tuberculosis, is the leading cause of death due to a 
single infectious agent worldwide. Approximately one quarter of the world’s population is infected with 
the bacterium, but only 5-15% will develop active TB (Houben and Dodd, 2016). The severity of this 
pandemic is exacerbated by the emergence of multidrug-resistant and extensively drug-resistant 
(MDR and XDR) M. tuberculosis strains. Although vital to the affected individual, it is clear that 
antimycobacterial treatment alone will not eradicate this disease. Host-directed therapy is emerging 
as a complementary approach to reduce the global TB burden, but will require an improved 
understanding of the host immune response and the genetic mechanisms that underlie it (244). To 
date, variants of genes involved in both the innate and adaptive immune responses have been 
associated with TB (reviewed by (245)). However, these investigations have been largely aimed at 
the autosome, while excluding the X chromosome. Given the high density of immune related genes 
on the X chromosome (144) and the fact that TB presents with a clear sex bias across populations, 
this is a serious oversight (246).  
In most countries the TB notification rate is twice as high in HIV negative males than in HIV negative 
females  (246). This ratio ranged from 1.56 to 2.73 and while it differs between countries, it was clear 
that more men than women are affected regardless of ethnicity or geographical location. 
Epidemiological data has shown that males and females differ in infection prevalence, varying rates 
of progression, differences in incidence of clinical disease and mortality rates due to TB (247). The 
cause of this male sex bias is not fully understood, but may include socioeconomic and behavioural 
factors, such as the underreporting of female cases and/or access to healthcare (166,248–250). 
However, these differences in case reporting may influence the bias but cannot explain the consistent 
global trend for male bias in TB (165). In a large meta-analysis including 29 surveys from 14 countries, 
a strong male bias was found in both TB notifications and prevalence and it was concluded that access 
to healthcare is not a confounding factor (251). This was replicated by Salim et al. (248)  who 
conducted a survey of 223 936 individuals in Bangladesh and identified 7 001 TB suspects at a female 
to male ratio of 0.52:1. Sputum was obtained from these individuals and 64 positive TB cases were 
identified at a female to male ratio of 0.33:1. These observed ratios did not differ much and were in 
fact lower than the female to male ratio observed through diagnosis in clinics which stood at 0.42:1. 
The authors concluded that reduced access of women to health care facilities does not significantly 
influence the bias seen (248). In a study conducted in Syria, men and women did not have different 
knowledge or attitudes towards TB, but women reported more barriers to seeking health care. They 
were more likely to comply with treatment and had higher treatment success rates compared to men 
which could influence the bias when it comes to TB mortality (252). Furthermore, men seem to engage 
in more “high risk” TB activities, including traveling, smoking, going to bars, and hazardous careers 
(e.g. mining) (165). In high burden countries more men than women engage in smoking and it has 
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been suggested that smoking may explain up to one third of the gender bias observed in TB (253). 
Alcohol consumption could have a similar effect. However other risk factors, specifically HIV infection 
and proximity to household contacts appear to have a female bias, which suggests that although 
behaviour may influence the bias it is not sufficient to fully explain the existing sex bias in TB (165). 
Another contributing factor may be the influence of sex hormones on the immune system (discussed 
in section 2).  
Females have been shown to have a more robust immune system (as described in section 5) and 
this is in part mediated by sex hormones that control development and maturation of immune cells 
(T-cells, macrophages, neutrophils) involved in combating TB. Type 1 T helper cells (Th1) are affected 
differently by male and female sex hormones. Testosterone upregulates IL-10 while down regulating 
IFN-γ (254), and estrogen increases IFN-γ, TNFα and IL-12 production while supressing production 
of IL-10 (255). Macrophages, which play a central role in controlling TB through active killing of 
mycobacteria, are also influenced by sex hormones. The female hormone estradiol has been shown 
to enhance macrophage activation (173), while testosterone down regulates macrophage activation 
by decreasing expression of TLR4, a vital receptor for detecting M. tuberculosis and initiating the 
innate immune response (167). Neutrophils have recently garnered interest with regards to their role 
in protection against TB and have been proposed to be the predominantly infected phagocytic cell 
type in pulmonary tuberculosis (pTB) (256). Neutrophil recruitment to areas of infection needs to be 
balanced as under and over recruitment of neutrophils can have a detrimental effect on tissue 
pathology (257). In response to trauma, testosterone decreases neutrophil activation while estrogen 
increases it, but the effect of this on TB is unknown and requires further investigation (258). As 
neutrophil recruitment needs to be balanced to avoid under or over recruitment to sites of infection it 
stands to reason that the regulation of this recruiting mechanism is of vital importance. In fact, miRNA-
223 (Xq12, figure 1), previously identified to be involved in the immune response by Pinheiro et al. 
(259) can limit recruitment of neutrophils by down regulating chemokine (C-X-C motif) ligand 2 
(CXCL2) and chemokine (C-C motif) ligand 3 (CCL3). Mice with a miRNA-223 knockout were more 
susceptible to M. tuberculosis,  due to excessive neutrophil accumulation in the lungs which 
subsequently led to tissue damage (260). Given that miRNA-233 is X-linked, is subject to the effects 
of skewed inactivation or may escape silencing, it could be differentially expressed between males 
and females. Up regulation due to escape from silencing or preferential expression of one gene copy 
due to skewed inactivation could down regulate recruitment and thus the pathological accumulation 
of neutrophils leading to a sex bias in TB susceptibility. Clearly these factors do not fully explain the 
male bias associated with TB disease development, suggesting that the host genotype, specifically 
the X chromosome, may also contribute.  
The third possible reason for the sex bias in TB susceptibility is linked to the X chromosome where 
skewed inactivation or genes escaping silencing could give females an enhanced immune response 
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against M. tuberculosis. Some of the earliest evidence of this X-linked genetic contribution to sex bias 
in TB susceptibility came from the “Lübeck Disaster” in 1929. Bacillus Calmette–Guérin (BCG) 
vaccine accidentally contaminated with M. tuberculosis was administered to 251 neonates. 173 of 
these children developed signs of active TB but recovered, while 72 died and during follow-up male 
children were more likely to have poor outcomes than females (261). Evidence from studies of 
Mendelian susceptibility to mycobacterial disease (MSMD) also supports the influence of the X 
chromosome to disease susceptibility. MSMD is a rare congenital syndrome that results in the 
predisposition to diseases caused by non-virulent mycobacteria, BCG vaccines and environmental 
mycobacteria known not to be disease causing in humans (262). MSMD is classified into two types, 
where autosomal MSMD is linked to defects in 5 autosomal genes (IFNGR1, IFNGR2, STAT1, 
IL12RB1 and IL12B) involved in the interleukin 12/23 dependant interferon γ (IFN-γ) mediated 
immune response (263). On the other hand X-linked recessive (XR)-MSMD is less well understood 
(163). Several genetic defects have been proposed to cause XR-MSMD, and based on the genes 
involved, XR-MSMD can be further subdivided into two types, XR-MSMD type 1 and XR-MSMD type 
2. Type 1 XR-MSMD is caused by mutations in the leucine zipper domain of the NF-kB essential 
modulator (NEMO) gene, which selectively impairs the CD40 and NF-kB/c-Rel-mediated induction of 
IL-12 production by monocytes and monocyte derived dendritic cells (262). Predisposition of type 2 
XR-MSMD is increased by mutations in two regions on the X chromosome, Xp11.4-Xp21.2 (129 
known genes) and Xq25-Xq26.3 (70 known genes). These regions may cause XR-MSMD 
independent of NEMO and Bustamante et al. (264) proposed that variants in the cytochrome b-245 
beta polypeptide (CYBB) gene could predispose to XR-MSMD-2 due to their selective effect on 
macrophages. CYBB encodes the gp91 protein, which is an essential component of the NADPH 
oxidase complex and severely affects respiratory burst in macrophages, thereby impeding their 
function and predisposing to XR-MSMD-2. NEMO and CYBB are both X-linked genes that affect 
immune related cells and as such can alter susceptibility to TB. XR-MSMD, like TB, shows a sex bias 
and affects more males than females which can be attributed to females carrying two X chromosomes. 
If one of the X chromosomes carries a defective NEMO or CYBB gene random XCI can result in the 
functional gene product still being expressed and reducing the risk of disease. Skewed inactivation or 
escape from silencing could further increase the observed sex bias as NEMO and CYBB have a low 
(stratum S1) and high (stratum S4) chance of escaping inactivation (figure 1). However, TB in 
immunocompetent individuals is a multigenic disease linked to variants in multiple genes that have a 
cumulative effect on disease susceptibility and is even further complicated by gene-gene interactions.  
The first genome-wide linkage analysis of TB susceptibility identified the chromosome Xq26 region 
as containing susceptibility genes, but did not specifically investigate sex bias (265). Although no 
specific genes could be identified, the CD40 ligand encoded by the TNFSF5 gene at Xq26.3 showed 
promise (figure 1), but requires further investigation (265). A study by Campbell et al. (266) on 121 
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TB cases and their parents identified a TNFSF5 (a CD40 ligand) variant (-726) to be associated with 
TB susceptibility in males. However, they failed to replicate this association in a West African cohort 
of 1200 individuals. 
More recently, sex-specific associations with genetic variants in the X-linked toll-like receptor (TLR) 8 
gene (Table 2), which encodes a pattern recognition receptor, were identified (132,134–138). Davila 
et al. (135) identified four variants in TLR8 (rs3764879, rs3788935, rs3761624 and rs3764880) that 
were significantly associated with TB susceptibility in Indonesian males, but not females. These 
findings were validated in a male only cohort from Russia and all four variants were again significantly 
associated with TB susceptibility in males (267). A second study conducted in a paediatric Turkish 
cohort showed a significant association between rs3764880 and TB susceptibility in males but not 
females and rs3764879 showed no significant association in this cohort (268). Hashemi-Shahri et al. 
(136) also investigated the influence of rs3764880 on TB susceptibility in a cohort from Iran but found 
no association in either males or females. Significant associations were found for both males and 
females in a Pakistani cohort for rs3764880, but males were more strongly associated (p=0.0013 for 
females and p<0.0001 for males) (269). Salie et al. (138) was the first to identify an association 
between rs3761624 and TB disease in females only (p<0.001 for females and p=0.164 for males). 
Two SNPs, namely rs3764879 and rs3764880, were also investigated in this South African Coloured 
(SAC) population and were significantly associated in both males and females, but with opposite 
effects. Finally, Lai et al. (137) showed that rs3764879 was significantly associated with TB in males 
but not females. The conflicting results of these studies investigating TLR8 may be explained by 
cohort size, ethnicity, M. tuberculosis strain and environmental factors.  
It is clear that the X chromosome and XCI (section 5) is significantly involved in TB susceptibility and 
the male sex-bias and future studies will need to focus on elucidating these effects. Fully 
understanding the sex-biased nature of TB will allow for medication tailored to a specific sex, which 
could improve treatment outcome, decrease the global TB burden and stem the tide of emerging drug 
resistant M. tuberculosis strains.   
Table 2.2: TLR8 association studies from different populations. 
Study Cohort Case Control SNP Allele Gender OR* 95% CI* P-value 
Davila 
et al. 
(135) 
Indonesia 
 
77 49 rs3764879 C Male 1.9 1.2-2.7 0.012 
76 74 rs3764879 C Female 1.1 0.8-1.7 0.44 
76 51 rs3761624 A Male 1.8 1.2-2.8 0.007 
76 74 rs3761624 A Female 1.1 0.8-1.7 0.44 
76 50 rs3788935 A Male 1.8 1.2-2.7 0.017 
76 74 rs3788935 A Female 1.1 0.8-1.7 0.44 
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Study Cohort Case Control SNP Allele Gender OR* 95% CI* P-value 
76 51 rs3764880 A Male 1.8 1.2-2.9 0.007 
76 74 rs3764880 A Female 1.1 0.8-1.7 0.44 
Russia 
 
1067 994 rs3764879 C Male 1.2 1.02-1.48 0.03 
1069 997 rs3788935 A Male 1.2 1.02-1.48 0.03 
1070 1000 rs3761624 A Male 1.2 1.01-1.46 0.04 
1069 997 rs3764880 A Male 1.2 1.02-1.48 0.03 
Dalgic 
et al. 
(134) 
Turkish 
children 
72 62 rs3764880 A Male 0.43 0.16-0.72 0.007 
156 124 rs3764880 A Female NS NS NS 
72 62 rs3764879 C Male NS NS NS 
156 124 rs3764879 C Female NS NS NS 
Hashem
i-Shahri 
et al. 
(136) 
Iran 
77 62 rs3764880 G Male 1.15 0.84-1.59 0.80 
196 166 rs3764880 G Female 1.15 0.75-1.75 0.51 
Bukhari 
et al. 
(132) 
Pakistan 
45 22 rs3764880 A Male / / <0.0001 
58 65 rs3764880 A Female 0.363 0.199-
0.660 
0.0013 
Salie et 
al. (138) 
SAC 
204 99 rs3761624 A Male / / 0.164 
217 336 rs3761624 A Female 1.54 1.19-1.99 <0.001 
205 99 rs3764879 C Male 0.72 0.55-0.93 0.013 
220 334 rs3764879 C Female 1.41 1.08-1.83 0.011 
1887 81 rs3764880 A Male 0.75 0.57-0.98 0.036 
199 306 rs3764880 A Female 1.42 1.09-1.87 0.011 
Lai et al. 
(137) 
Chinese 
96 146 rs3764879 C Male 4.04 1.82-8.99 <0.001 
40 97 rs3764879 C Female 5.05 0.44-57.38 0.191 
*OR: Odds ratio; 95% CI: 95% confidence interval 
2.9 Discussion and concluding remarks 
It is clear that sex-specific effects contribute to infectious disease susceptibility and females have a 
major immunological advantage over males. Understanding the origin of sex bias could guide 
treatment by allowing sex-specific diagnostic and treatment regimes, thereby decreasing time to 
initiation of treatment as well as increasing treatment success of diseases with sex differences. The 
X chromosome may contribute to the missing heritability or contain biomarkers that could be used as 
diagnostic tools. As analytical tools are now available to fully include the X chromosome in genetic 
analyses, it is clear that the X chromosome should not be ignored. Importantly, due to the haploid 
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nature of males the power to detect a significant association will be halved when compared to a female 
cohort of similar size and this could have an effect on the results of sex-stratified analysis. Thus, care 
must be taken when analysing results, and a non-significant association in one sex does not imply 
that that specific sex is not affected by the variant but could simply be as a result of insufficient power 
to detect a sex specific association. 
While socioeconomic and behavioural factors as well as sex hormones do influence sex bias, these 
factors do not fully account for it, which leads to the conclusion that the X chromosome itself is likely 
to greatly influence the immune response and sex bias in disease susceptibility. The X chromosome 
contains multiple immune-related genes and immune regulatory elements as well as the XIC that 
regulates X chromosome inactivation. It is therefore clear that the X chromosome is involved in the 
immune response and genes that escape inactivation or are preferentially inactivated could influence 
the dosage of X-linked gene expression between the sexes and as such could further influence the 
sex bias in disease. It is thus of vital importance that the XCI mechanisms be further investigated to 
understand all the regulatory elements involved and the contribution to sex bias. Furthermore, the 
role of the X chromosome in the innate and adaptive immune response should be extensively 
investigated to determine how it contributes and differs between the sexes. Elucidating the function 
of the X chromosome and including it in biological studies and analyses could improve the 
understanding of complex diseases such as TB.  
2.10 Declaration 
2.10.1 Competing interest 
 The authors report no conflict of interest. 
2.10.2 Funding 
This research was partially funded by the South African government through the South African 
Medical Research Council and the National Research Foundation of South Africa. 
2.11 Acknowledgements 
 This research was partially funded by the South African government through the South African 
Medical Research Council. The content is solely the responsibility of the authors and does not 
necessarily represent the official views of the South African Medical Research Council. This 
work was also supported by the National Research Foundation of South Africa. This work was 
also supported by a Strategic Health Innovation Partnership grant from the South African 
Medical Research Council and Department of Science and Technology/South African 
Tuberculosis Bioinformatics Initiative (SATBBI, GW) to GT.
Stellenbosch University  https://scholar.sun.ac.za
32 
 
3 Global ancestry inference on the autosome and X 
chromosome identifies sex-biased admixture in a highly 
admixed population. 
Haiko Schurz 1,2, Caitlin Uren1, Meng Lin3 , Craig J Kinnear 1, Paul D van Helden 1, Gerard Tromp 1,2,4, 
Brenna Henn 5, Eileen G Hoal 1, Marlo Möller 1 
1 DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical 
Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human 
Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South 
Africa.  
2 South African Tuberculosis Bioinformatics Initiative (SATBBI), Faculty of Medicine and Health 
Sciences, Stellenbosch University, Cape Town, South Africa. 
3 Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine, 
University of Southern California, Los Angeles, CA 90033 
4 Centre for Bioinformatics and Computational Biology, Stellenbosch University, Cape Town, South 
Africa. 
5 Department of Anthropology, and the UC Davis Genome Center, University of California, Davis, CA, 
95616. 
  
Stellenbosch University  https://scholar.sun.ac.za
33 
 
3.1 Abstract  
Recently admixed populations provide us with a unique opportunity to study population history and 
fine-map disease loci. The South African Coloured population is a complex admixed group with at 
least 5 ancestral populations (Bantu-speaking African, KhoeSan, European, South and East Asian). 
Previous studies suggested the presence of sex-biased admixture within this population, as well as 
others in South Africa, however, the evidence for sex-biased admixture is limited and under-
investigated. Determining sex-biased admixture can inform recent population dynamics and it is vital 
to include this as a confounder during X-linked association studies of diseases that present with a 
sex-bias.  
Significant sex-biased admixture for Bantu-speaking African, KhoeSan and European ancestry was 
identified using global admixture inference. The results presented here correlate with previous results 
based on mtDNA and Y chromosome markers, revealing a female bias for the KhoeSan and a male 
bias for the European and Bantu-speaking African ancestral components. The Asian components did 
not present a strong bias in this admixed population.  
Here we show that global ancestry inference on the autosome and X chromosome can successfully 
be used to quickly and accurately identify the presence of sex-biased admixture in a highly admixed 
population, without the need for mtDNA and Y chromosome data.  
3.2 Introduction 
Genetic admixture is the process by which new genetic lineages are introduced into a population 
through the interbreeding of two or more previously isolated populations (270). Analysing the 
distribution of ancestral components in recently admixed individuals allows the study of population 
history and natural selection and can even be used to fine-map disease-causing variants (94,99). 
Previous investigations into sex-bias were done by comparing admixed and ancestral lineages using 
genetic material inherited from only one sex such as mitochondrial DNA (mtDNA) in females and the 
Y chromosome in males. By identifying the source populations of lineages present in the mtDNA and 
Y chromosomes of an admixed group, sex-biased admixture can be elucidated. A female bias is 
present when lineages from a specific ancestral population are increased in the mtDNA compared to 
the Y chromosome (271). This type of analysis has been used to identify sex-biased admixture in 
Icelanders (272), Tibeto-Burman (273), Native Americans (274,275), African Americans (276,277) 
and the SAC population (278).  
An alternative method of investigating sex-biased admixture is to analyse the ancestral distribution 
on the X chromosome compared to the autosome. This method is dependent on the X chromosome 
spending 2/3 of its time in females while undergoing recombination and 1/3 of its time in males without 
recombination. In contrast, autosomes always experiences recombination and as a result the X 
chromosome retains longer linkage disequilibrium blocks than the autosome, which can be used to 
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investigate sex-bias (146,147). In a 2-way admixed population, if the mean ancestral component of 
population 1 is higher on the X chromosome than the autosome then this is an indication of female 
sex-bias from ancestral population 1 and male bias from ancestral population 2. It could however also 
indicate a female bias from both population 1 and 2, but a higher contribution from population 1. 
Alternatively it could indicate a male bias from both population 1 and 2 with more influx from population 
2 (279). As a result of these alternative interpretations, historical evidence should always be used to 
corroborate the findings. This method quickly and effectively indicates sex-biased admixture and was 
previously implemented successfully in a three-way admixed African-American and Hispanic 
population (156–158). Computer simulations indicate that the method has high accuracy in 
populations that experienced a single admixture event, but it is less accurate if the population 
experienced continuous admixture (14). The SAC population is characterised by recent, continuous 
admixture (85,278), so it is unclear how well this method will perform. Furthermore, this method has 
not been tested on a complex admixed population such as the SAC.  
The SAC population arose from relatively recent admixture resulting from the early encounters of 
European and Bantu-speaking African males with KhoeSan females at the Cape of Good Hope (South 
Africa) approximately 350 years ago (278,280). Ancestral contributions from the KhoeSan, Bantu-
speaking African, European and South and East Asian populations are present in this group(278,280). 
Previous work using mtDNA and Y chromosome markers has shown that the ancestral distribution 
among SAC individuals is characterised by sex-biased admixture (278). The KhoeSan and South and 
East Asian ancestral components were female biased, while the European and Bantu-speaking 
African components were male biased (278).  
We performed sex-biased admixture analysis in the SAC by investigating the distribution of ancestral 
components between the autosome and X chromosome. The results were compared to previous 
mtDNA and Y chromosome data to assess how accurately the admixture method calculates sex-bias 
in a 5-way admixed population.  
3.3 Methods 
3.3.1 Genotyping data 
DNA was extracted from blood samples of SAC individual’s as reported previously (281). Ethics 
approval was obtained from the Health Research Ethics Committee of Stellenbosch University 
(project registration number S17/01/013, 95/072 and NO6/07/132) before participant recruitment. 
Written informed consent was obtained from all study participants prior to blood collection. In total 800 
samples from the SAC were genotyped on the Illumina Multi ethnic genotyping array (MEGA, Illumina, 
Miami, USA). The reference populations used to infer ancestry were Europeans (Utah Residents with 
Northern and Western European Ancestry) and South Asian (Gujarati Indians in Houston, Texas and 
Pathan of Punjab) obtained from the 1000 Genomes Phase 3 data (81) and East Asian (Han Chinese 
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in Beijing, China and Japanese, Tokyo, Japan), African (Luhya in Webuye, Kenya, Bantu-speaking 
African, Yoruba from Nigeria) and KhoeSan (Nama/Khomani) (103,282). The Zcall software was used 
to recall rare genotypes (MAF < 5%) for all datasets before aligning them to the 1000 Genomes Phase 
3 reference panel and removing all ambiguous variants (81,283). PLINK v 1.07 (284) was used to 
check for sex concordance prior to merging all datasets. The merged data was filtered for Hardy 
Weinberg Equilibrium (<0.05), minor allele frequency (<0.03) and individual and SNP missingness 
(>10%) using PLINK (v1.07). Finally, all variants on the X chromosome that were heterozygous in 
males were removed and the merged dataset was checked for ambiguous variants using PLINK 
(v1.07) and snpflip3 version v0.0.6 respectively.  
3.3.2 Admixture analysis 
For the admixture analysis the software ADMIXTURE 1.3 was used (154). Due to the level of 
relatedness in the SAC and the limited number of individuals per reference population, the SAC 
individuals were split into 20 running groups. A running group is a set of unrelated individuals for 
which admixture is to be inferred. Due to the limited number of reference individuals not all SAC data 
can be run simultaneously and thus needs to be split up. Each running group contains on average 42 
unrelated SAC individuals, matching the number of individuals per reference population. Relatedness 
for the SAC was determined from the genotyping data using the software KING (version 2.1.4) (285). 
For each running group, Admixture was inferred five times at random seed values for both the 
autosome and X chromosome separately. For the X chromosome the ADMIXTURE software was run 
in haploid mode for males (--haploid=”male:23”) in order to ensure accurate admixture inference for 
haploid genotypes (286). The values for the five runs were then averaged for each individual before 
the results were analysed. ADMIXTURE was run at K=5 as we were interested in the 5 main SAC 
ancestral components. Pong (version 1.4.7) was used to visualise the admixture results across all 
runs (287). 
3.3.3 Sex-bias analysis 
Sex-bias was analysed by comparing the distribution of each ancestral component between the 
autosome and X chromosome. The data was assessed for normality (Figure S3.1) upon which a 
Wilcoxon signed rank test (a paired test for skewed data) was implemented, using the R programming 
environment (version 3.2.4 (142)), to determine significant differences in ancestral distribution. Since 
5 ancestral populations were investigated, the Bonferroni correction for multiple tests was applied for 
the 5 tests performed, at a family-wise alpha threshold of 0.05. The results were also compared to 
previous results on sex-biased admixture in the SAC using mtDNA and Y chromosome markers in 
order to determine how the X chromosome-based sex-bias analysis compares.  
                                               
3 https://github.com/biocore-ntnu/snpflip 
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3.4 Results 
Following quality control and merging of the data, a total of 558,213 autosomal and 13,399 X 
chromosome variants overlapped between all the datasets. The results for the global ancestry 
inference are shown in Figure 3.1 and 3.2 and the mean and standard deviations of each ancestral 
component are shown in Table 3.1 for both the autosome and X chromosome. On average the SAC 
individuals possess 28% Bantu-speaking African, 20.5% European, 27.1% KhoeSan, 14.7% South 
Asian and 9.6% East Asian ancestry on the autosome. These mean autosomal ancestral components 
reflect previous results of admixture analysis in the SAC population (85,99) ensuring accuracy of the 
inference. As shown in Table 3.1 and Figure 3.2 the mean for the Bantu-speaking African (p-value = 
7.16e-5) and European (p-value = 1.47e-31) component is significantly larger on the autosome, 
following multiple test correction, suggesting a male bias. Contributions from the KhoeSan population 
(p-value = 1.78e-20) present with a significantly higher mean on the X chromosome compared to the 
autosome, indicating a female bias. The East Asian component passed the significance threshold (p-
value = 0.038) following multiple testing correction (female bias), while the South Asian component 
did not reach statistical significance (p-value = 0.32), but the mean values for the South Asian 
components were slightly higher in females compared to males. 
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Figure 3.1: Admixture plot for all SAC and reference individuals for the autosome (A) and X chromosome (B). Each column represents one 
individual and all individuals are aligned between (A) and (B). 
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Table 3.1: Sex-biased distribution of each ancestral component. 
Population 
Median Mean 
Bias 
p-value 
adjusted Autosome X chromosome Autosome X chromosome 
African 0.236 0.203 0.280 0.267 Male 7.16e-5 
European 0.153 0.051 0.205 0.162 Male 1.47e-31 
KhoeSan 0.261 0.294 0.271 0.328 Female 1.78e-20 
South Asian 0.112 0.061 0.147 0.148 Female 3.20e-1 
East Asian 0.055 0.028 0.096 0.099 Female 3.80e-2 
 
 
Figure 3.2: Boxplot of Autosomal (grey) and X chromosome (green) ancestral components 
indicating median values (thick black line), first and third quartile (box) and range (whiskers). 
3.5 Discussion  
We used global ancestry inference on the autosome and X chromosome to detect sex-biased 
admixture in the 5-way admixed SAC population. Previous sex-bias analysis of this population using 
mtDNA and Y chromosome markers indicated that the SAC population has a strong female KhoeSan 
bias with 60% of mtDNA and between 5.3% - 20% Y chromosome lineages originating from the 
KhoeSan population. The Bantu-speaking African and the European lineages indicated a male bias 
with a 19% mtDNA and at least 24% Y chromosome lineages from Bantu-speaking African 
populations and a 4.6% mtDNA and 32.5% Y chromosome lineages from European populations. 
Finally, for the South and South East Asian components previous results indicate only slight 
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differences between maternal and paternal contributions (278). For the South Asian component 8.7% 
mtDNA and 9.6% Y chromosome lineages were identified, while the South East Asian component 
had 7.6% mtDNA and 7.4% Y chromosome lineages, suggesting no sex-bias for the Asian 
components (278).  
Our results show concordance with previous findings, which indicate a significant male bias from 
Bantu-speaking African and European ancestral populations and a significant female bias for the 
KhoeSan component (Table 3.1). For the South and East Asian component, the differences between 
maternal and paternal contributions were not significant in previous studies, whereas here we 
identified a significant East Asian female bias in the SAC population. The South Asian component 
was not significantly different between the autosome and X chromosome and indicated a marginal 
female bias in our data while Quintana-Murci et al. (2010) showed a marginal male bias (based on 
mean values, but no statistical significance). The discrepancy in the Asian component between the 
two studies can be explained. It could simply be a result of the variation in ancestral distribution 
observed when ancestry is inferred for different individuals of the same population. As the differences 
for the Asian ancestral component between the studies is small, it could be explained by this variation 
in ancestral distribution. Furthermore, Quintana-Murci et al. (278) analysed only 20 SAC individuals 
using 64 mtDNA markers, 46 Y chromosome repeats and 14 Y chromosome tandem repeats. This 
could result in an inaccurate presentation of population-wide ancestral components which could affect 
the accuracy of the results. This accuracy could be further affected by the limited number of mtDNA 
and Y chromosome markers used to detect ancestral lineages. For this study the SNP density, 
number of individuals per reference population and SAC sample size was considerably larger, leading 
to more precise admixture inference. The increased precision could explain why a significant 
difference for the East Asian component and a marginal female bias for the South Asian component 
is identified in our study. However, increased precision in admixture inference does not imply 
increased accuracy for determining sex-biased admixture. In order to fully quantify the accuracy of 
the admixture method further studies using mtDNA and Y chromosome data from more individuals 
and with more typed markers are required, especially to fully elucidate the contributions from Asian 
populations.  
Despite the slight discrepancy in the results for the Asian components this analysis reveals that global 
ancestry inference can be used to accurately infer sex-bias in a 5-way admixed population. However, 
the accuracy of the results will depend on the precision of admixture inference and it is thus vital to 
ensure that appropriate reference populations are used (85,288). One potential limitation in this 
analysis was the fact that the SAC population experienced continuous admixture. Simulations that 
compared autosomal and X chromosome ancestral distributions lacked accuracy in populations that 
experienced continuous admixture (279). However, this was not the case for this study as it was 
possible to precisely determine sex-biased contributions from Bantu-speaking African, KhoeSan and 
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European populations, but not for Asians. This could be due to the smaller Asian genetic contribution 
to the SAC population and not necessarily due to continuous admixture events.  
Determining sex-biased admixture can inform on recent population dynamics and socio-cultural 
factors associated with the founding of emerging populations. Global admixture inference can be used 
to accurately infer sex-biased admixture in a 5-way admixed population and significant bias for Bantu-
speaking African, KhoeSan and European ancestry were identified in this study.  
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3.7 Supplementary material  
 
Figure S3.1: Histograms of the five ancestral components indicating data that is not normally 
distributed.
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4.1 Abstract 
Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a complex disease with a known human 
genetic component. Males seem to be more affected than females and in most countries the TB 
notification rate is twice as high in males as in females. While socio-economic status, behaviour and 
sex hormones influence the male bias they do not fully account for it. Males have only one copy of 
the X chromosome, while diploid females are subject to X chromosome inactivation. In addition, the 
X chromosome codes for many immune-related genes, supporting the hypothesis that X-linked genes 
could contribute to TB susceptibility in a sex-biased manner. We report the first TB susceptibility 
genome-wide association study (GWAS) with a specific focus on sex-stratified autosomal analysis 
and the X chromosome. A total of 810 individuals (410 cases and 405 controls) from an admixed 
South African population were genotyped using the Illumina Multi Ethnic Genotyping Array, 
specifically designed as a suitable platform for diverse and admixed populations. Association testing 
was done on the autosome (827386 variants) and X chromosome (20939 variants) in a sex stratified 
and combined manner. SNP association testing was not statistically significant using a stringent cut-
off for significance but revealed likely candidate genes that warrant further investigation. A genome 
wide interaction analysis detected 16 significant interactions. Finally, the results highlight the 
importance of sex-stratified analysis as strong sex-specific effects were identified on both the 
autosome and X chromosome.  
4.2 Key words 
Tuberculosis, GWAS, Sex-bias, Host genetics, X chromosome, sex-stratified, susceptibility  
4.3 Introduction  
Tuberculosis (TB) caused by Mycobacterium tuberculosis (M. tuberculosis) is a global health epidemic 
and the leading cause of death due to a single infectious agent (246). In 2016 1.3 million TB deaths 
were reported in HIV negative individuals and an additional 374000 deaths related to TB/HIV co-
infection were recorded. The majority of these deaths occurred in southeast Asian and African 
countries (246). TB is a complex disease, influenced by environmental and behavioural factors such 
as socio-economic status and smoking, as well as definite human genetic components. The 
contribution of the host genes to disease has been highlighted by numerous investigations, including 
animal (74), twin (59,289,290), linkage (70,265) and candidate gene association studies (291). More 
recently genome-wide association studies (GWAS) in diverse populations have been done (123–
131,133).  
Interestingly another influential factor in TB disease development is an individual’s biological sex, 
which has been largely ignored in past TB studies and was usually only used as a covariate for 
adjusting association testing statistics. In 2016, males comprised 65% of the 10.4 million recorded TB 
cases, indicating that the TB notification rate is nearly twice as high in males as in females (WHO, 
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2017). While socio-economic and behavioural factors do influence this ratio, it does not fully explain 
the observed sex-bias (140). Another factor that influences sex-bias is the effect that sex hormones 
(estrogen and testosterone) have on the immune system. Estrogen is an immune activator, 
upregulating pro-inflammatory cytokines (TNFα), while testosterone is an immune suppressor, 
upregulating anti-inflammatory cytokines (IL-10) (171). This could explain why men are more 
susceptible to infectious diseases compared to females (140). However, as sex-based differences in 
immune responses differ even between pre-pubertal boys and girls, as well as between post-
menopausal women and elderly men, it shows that sex hormones do not fully explain the sex-bias 
(144). Thus, it has been proposed that the X chromosome and X-linked genes directly contribute to 
the observed sex-bias.  
There are approximately 1500 genes on the X chromosome, many of which are involved in the 
adaptive or innate immune system (161). Since females have two X chromosomes, one requires 
silencing in order to equalise dosage of gene expression to that of men who only have one X 
chromosome. This silencing occurs randomly in each cell, making females functional mosaics for X 
linked genes and giving them a major immunological advantage over males (140). As males are 
haploid for X-linked genes any damaging polymorphisms or mutations on the X chromosome will have 
a more pronounced immunological effect in males than in mosaic females, thereby influencing the 
sex-bias (160). 
To date, eleven GWAS investigating susceptibility to clinical TB have been published (123–
131,133,292). There has not been significant overlap between the 11 published TB GWAS, but it 
seems that replication is more likely when populations with similar genetic backgrounds are 
compared: the WT1 locus was associated with disease in populations from West and South Africa 
(130,133). Critically, genotyping microarrays that did not fully accommodate African genetic diversity 
were used in these studies (123,124,130,131,133). It is therefore possible that unique African-specific 
susceptibility variants were not tagged by these initial arrays, since linkage disequilibrium (LD) blocks 
are shorter in African populations (293). Moreover, none of the GWAS included or examined the X 
chromosome or sex-stratified analysis of the autosomes as was done in an asthma cohort (294). 
Genetic differences between asthmatic males and females were identified on the autosome, with 
certain alleles having opposite effects between the sexes. Candidate gene association studies 
provide independent confirmation of the involvement of the X chromosome in TB susceptibility, 
through the association of X-linked TLR8 susceptibility variants with active TB. Davila et al. (295) 
investigated 4 TLR8 variants (rs3761624, rs3788935, rs3674879, rs3764880) in an Indonesian cohort 
and showed that all variants conferred susceptibility to TB in males but not females. The results for 
males were validated in male Russian individuals (295). These results were validated for rs3764880 
in Turkish children, but no significant association was found for rs3764879 (296). Hashemi-Shahri et 
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al. (136) found no significant TLR8 associations in an Iranian population, while rs3764880 was 
significantly associated with TB susceptibility in both males and females in a Pakistani cohort (132). 
In admixed South African Coloured (SAC) individuals rs3764879 and rs3764880 were significantly 
associated in both males and females, while rs3761624 was only significantly associated in females 
(138). Interestingly, in this cohort opposite effects were consistently found between the sexes for the 
same allele in all investigated TLR8 variants (138), echoing the asthma findings of Mersha et al (294). 
Finally, in a Chinese cohort rs3764879 was significantly associated with TB disease in males but not 
females. While many of these variants did not reach genome wide significance they still provide 
evidence of the involvement of X-linked genes in TB susceptibility. 
We report the first TB susceptibility GWAS with a specific focus on sex-stratified autosomal analysis 
and the X chromosome to elucidate the male sex-bias. Individuals from the unique five-way admixed 
South African Coloured (SAC) population, with ancestral contributions from Bantu-speaking African, 
KhoeSan, European, South and East Asian groups were genotyped in this study (86,297). These 
genetic contributions are due to both the complex colonisation history of South Africa and the 
country’s importance as a refreshment station on major trade routes during the fifteenth to nineteenth 
century (103,298). This is therefore the first GWAS in the SAC that uses an array (Illumina Multi Ethnic 
Genotyping Array, see Section 2.2) specifically designed to detect variants in the 4 most commonly 
studied populations, making it the most suitable platform for diverse and admixed populations at the 
time of genotyping.  
4.4 Materials and methods 
4.4.1 Study population 
Study participants were recruited from two suburbs in the Cape Town metropole of the Western Cape. 
These suburbs were chosen for its high TB incidence and low HIV prevalence (2%) at the time of 
sampling (1995-2005) (299). Approximately 98% of the residents in these suburbs self-identify as 
SAC and have similar socio-economic status, which reduces confounding bias in the association 
testing (133). The cohort consists of 420 pulmonary TB (pTB) cases, bacteriologically confirmed to 
be culture and/or smear positive and 419 healthy controls from the same suburbs. Approximately 80% 
of individuals over the age of 15 years from these suburbs have a positive tuberculin skin test (TST) 
, indicating exposure to M. tuberculosis (300). All study participants were over 18 years of age and 
HIV negative. 
Approval was obtained from the Health Research Ethics Committee of Stellenbosch University 
(project registration number S17/01/013 and 95/072) before participant recruitment. Written informed 
consent was obtained from all study participants prior to blood collection. DNA was extracted from 
the blood samples using the Nucleon BACC Genomic DNA extraction kit (Illumina, Buckinghamshire, 
UK). DNA concentration and purity were checked using the NanoDrop® ND-1000 Spectrophotometer 
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and NanoDrop® v3.0.1 software (Inqaba Biotechnology, Pretoria, SA). The study adhered to the 
ethical guidelines as set out in the “Declaration of Helsinki, 2013 (301).  
4.4.2 Genotyping 
Genotyping was done using the Illumina Multi-ethnic genotyping array (MEGA) (Illumina, Miami, USA) 
which contains 1.7 million markers from various ethnicities making it highly suitable for diverse and 
admixed populations. The array is based on novel variants identified by the Consortium on Asthma 
among African ancestry populations in the Americas (CAAPA), the Illumina human core content for 
European and Asian populations as well as multi-ethnic exome content from African, Asian and 
European populations. The array also contains ancestry informative markers specific to the SAC 
population. While the KhoeSan population is not highly represented on the array, which could lead to 
a certain level of ascertainment bias, at the time of genotyping it was the most suitable platform for 
this diverse and admixed populations. Genome studio v2.04 (Illumina, Miami, USA) was used for SNP 
calling to calculate intensity scores and to call common variants (MAF >= 5%), followed by analysis 
with zCall to recall rare genotypes (MAF <5%) (283).  
4.4.3 Genotyping quality control 
Quality control (QC) of the genotyping data was done using the XWAS version 2.0 software and QC 
pipeline to filter out low quality samples and SNPs (115,302). Data were screened for sex 
concordance, relatedness (up to third degree of relatedness) and population stratification (as 
determined by principal component analysis). Genotypes for males and females were filtered 
separately in order to maintain inherent differences between the sexes. SNPs were removed from the 
analysis if missingness correlated with phenotype (threshold = 0.01) as well as individual and SNP 
missingness (greater than 10%), minor allele frequency (less than 1%) and Hardy–Weinberg 
equilibrium (HWE) in controls (threshold = 0.01). Filtering continued iteratively until no additional 
variants or individuals were removed. Overlapping markers between the sexes were merged into a 
single dataset. X chromosome genotypes were extracted and variants were removed if the MAF or 
missingness was significantly different between the sexes (threshold = 0.01). A flow diagram 
explaining quality control steps and association testing of the data is shown in Figure S4.1. 
4.4.4 Admixture  
The SAC population is a 5-way admixed population with ancestral contributions from Bantu-speaking 
African populations, KhoeSan, Europeans and South and East Asians. To avoid confounding during 
association testing the ancestral components are included as covariates (99). Admixture was 
estimated for the autosome (chromosome 1-22) and the X chromosome separately using the software 
ADMIXTURE (v1.3) (303) and reference genotyping data for 5 ancestral populations. The reference 
populations used to infer ancestry were European (CEU) and South Asian (Gujarati Indians in 
Houston, Texas and Pathan of Punjab) extracted from the 1000 Genomes Phase 3 data (81), East 
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Asian (Han Chinese in Beijing, China), African (Luhya in Webuye, Kenya, Bantu-speaking African, 
Yoruba from Nigeria) and San (Nama/Khomani) (103,282). Due to the limited number of individuals 
availablefor each reference population the SAC data had to be divided into 21 groups to equal the 
number of individuals per reference population. The number of individuals per reference population 
and admixed population has to be kept consistent in order to maximise the accuracy of the admixture 
results by not over-representing one particular population in the analysis. Therefore, admixture 
inference was done separately for each of the 21 SAC groups, referred to as running groups. Each 
running group was analysed five times at different random seed values. The results for each individual 
were averaged across the five runs in order to obtain the most accurate ancestry estimations (286). 
Four ancestral components (African, San, European and South Asian(297)) were included as 
covariates in the logistic regression association testing with the smallest component (East Asian) 
excluded in order to avoid complete separation of the data.  
4.5 Association analysis 
4.5.1 SNP based association analysis  
Autosomal TB association testing was done with sex-stratified and combined datasets using the 
additive model in PLINK (version 1.74) (304) in order to detect sex-based differences.  TB association 
testing for the X chromosome were done separately in males and females using XWAS (version 2) 
and the results were combined using Stouffers method in order to obtain a combined association 
statistic (115,302). A sex-differentiated test was conducted for the X chromosome using the XWAS 
software to test for significant differences in genetic effects between males and females. SNP based 
association testing (sex-stratified or not) compares the frequency of alleles between cases and 
controls to determine if a specific allele co-occurs with a phenotype (TB) more often than would be 
expected by chance. The sex-differentiation test on the other hand compares the effect size (OR) of 
a variant between the sexes to determine if a variant has a different effect on risk between the sexes. 
The sex-differentiation test is explained in more detail by Chang et al. (302). X chromosome 
inactivation states were also included in the association testing as covariates using a method 
developed by Wang et al. (305). To include inactivation states in the association analysis the most 
likely state was determined for each SNP. A variant can either be inactivated, or it can be skewed 
towards the deleterious or normal allele or the variant can escape inactivation. To determine which of 
the four states is most probable the likelihood ratio for each one was calculated and the inactivation 
state that maximised the likelihood ratio was applied to the SNP in question. This was done for each 
variant as inactivation states vary along the X chromosome (for a detailed description see Wang et 
al. (305)). Ancestry, sex and age were included in the analyses as covariates where applicable. 
Information on other risk factors known to influence TB susceptibility such as smoking, and alcohol 
                                               
4http://pngu.mgh.harvard.edu/purcell/plink/ 
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consumption was not available for this study cohort and could not be included as covariates. Multiple 
testing correction was done using the SimpleM method (306), which adjusts the significance threshold 
based on the number of SNPs that explains 95% of the variance in the study cohort. This method is 
less conservative than Bonferroni correction and is a close approximation of permutation results in a 
fraction of the time. For the autosome the genome-wide significance threshold was set to 5.0e-8 (307). 
4.5.2 Gene based association analysis 
Gene-based association testing groups SNPs together and thus decreases the multiple testing 
burden and increase power to detect an association. Gene-based association testing was done using 
the XWAS v2 scripts, which were implemented using the Python5 (version 2.7.10) and R programming 
environment (version 3.2.4, (142)) and R packages corpcor and mvtnorm. Reference files for the 
known canonical genes on the X chromosome for human genome build 37 were included in the XWAS 
v2 software package and used to group variants and p-values by gene (115,302). Bonferroni 
correction was used to adjust for multiple testing instead of SimpleM, as all genes, unlike SNPs, are 
independent of each other in the context of association testing and as such the multiple test correction 
cannot be less than the number of genes tested. 
4.5.3 Interaction analysis 
Genome-wide SNP interaction analysis was done using CASSI6 (v2.51). A joint effects model was 
implemented for a rapid overview of interactions of all variants across the genome (autosome and X 
chromosome). Variants from significant interactions were reanalysed using a logistic regression 
approach with covariate correction, which would not be feasible for a genome-wide interaction 
analysis as it would be too computationally intensive. As there is no consensus on the significance 
threshold for genome wide interaction analysis Bonferroni correction was used in order to avoid 
potential inflation of false positive results. 
4.6 Results 
4.6.1 Cohort summary 
In total 410 TB cases and 405 healthy controls passed the sex-stratified QC procedure. General 
summary statistics for the cohort, including mean and standard deviation of age and global ancestry 
as well as the ratio of males to females in both cases and controls are shown in Table 4.1. Clear 
differences were observed between TB cases and controls for both age and ancestry, justifying the 
inclusion as covariates. Ancestral distributions were compared using the Wilcoxon signed-rank test 
and were shown to significantly differ (unpublished results) between the autosome and X 
chromosome (Figure 4.1). Y chromosome and mitochondrial haplogroup analysis also revealed 
strong sex biased admixture in the SAC population, with a strong female KhoeSan and male Bantu-
                                               
5 http://www.python.org  
6 https://www.staff.ncl.ac.uk/richard.howey/cassi/using.html  
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speaking African and European bias (278). As sex biased ancestry has been shown to reflect in strong 
differences between the autosomal and X chromosome ancestral components they were included as 
covariates in the respective analyses (156–158). 
Table 4.1: SAC sample characteristics showing case/control and sex distribution, mean and 
standard deviation of age and global ancestral components 
Group Number 
Female 
(%) Age San African European 
South 
Asian 
East 
Asian 
TB 
cases 
410 
242 
(59) 
36.32 ± 
11.04 
33.89  ± 
18.83 
29.11 ± 
19.80 
17.10 ± 
16.81 
12.95 ± 
10.82 
7.08 ± 
7.22 
Controls 405 
223 
(55)  
30.55 ± 
12.91 
33.75 ± 
19.59 
29.92 ± 
20.46 
16.12± 
15.81 
13.26 ± 
12.38 
7.04 ± 
7.44 
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Figure 4.1: Ancestral distribution on the X chromosome and autosome for males and females. 
4.6.2 Association testing results 
4.6.2.1 SNP based  
The top results for the autosomal association testing are shown in Table 4.2 and Figure S4.2, with 
the QQ-plot indicating no constraints on the analysis or inflation of the results (Figure S4.2). Following 
multiple test correction, no significant associations were identified for the combined or sex-stratified 
analysis, but it is important to note that the top associations differed between the sex-stratified and 
combined analyses as well as for males and females (Table 4.2). The top hit for the combined 
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autosomal association test was rs17410035 (OR= 0.4, p-value = 1.5e-6, Table 4.2), located in the 3’-
UTR of the DROSHA gene, which encodes a type 3 RNase. This RNase is involved in miRNA 
processing and miRNA biogenesis (308). Although little evidence exists that rs17410035 has an 
impact on DROSHA gene expression or miRNA biogenesis (which could affect gene expression) it 
has been associated with increased colon cancer (OR= 1.22, p-value = 0.014) (308) and cancer of 
the head and neck (OR= 2.28, p-value = 0.016) (309). When the rs17410035 SNP interacts with other 
variants (rs3792830, rs3732360) it can further increase the risk for cancer of the head and neck (309), 
which illustrates the importance of doing interaction analysis. For the autosomal sex-stratified analysis 
the variant with the lowest p-value in males was rs11960504 (OR = 2.8, p-value = 7.21e-6, Table 4.2) 
located downstream of the GRAMD2B gene, a gene for which no information is available. The top hit 
in the females was rs2894967 (OR = 2.17, p-value = 4.77e-6) located upstream of the TENT4A gene, 
a gene coding for a DNA polymerase shown to be involved in DNA repair (310). Closer inspection of 
the data revealed that the effects between the sexes were in the same direction for all top hits in the 
combined analysis, whereas all variants identified in the sex-stratified analysis had effects in opposite 
directions between the sexes, or one sex had no effect, indicating that even on the autosome strong 
sex specific effects are prominent.  
Table 4.2: Top associations for the combined and sex-stratified autosomal association testing. 
Chr SNP A1 Location Gene Group OR* 95CI* P-value 
5 rs17410035 T 5’UTR DROSHA Combined 0.404 0.28-0.58 1.50e-6 
5 rs1501847 G 5’UTR C5orf64 Combined 1.708 1.37-2.14 2.64e-6 
7 rs2665441 C 3’UTR ASNS Combined 1.681 1.34-2.10 5.51e-6 
9 rs1662230 G 5’UTR RN7SKP120 Combined 2.278 1.58-3.27 8.91e-6 
12 rs199911028 G Intronic CFAP54 Combined 2.966 1.89-4.67 2.58e-6 
15 rs142644068 C Intronic PCSK6 Combined 0.132 0.06-0.30 1.56e-6 
5 rs11960504 T 3’UTR GRAMD2B Male 2.801 1.79-4.39 7.21e-6 
13 rs9315991 A Intronic LINC00400 Male 0.394 0.27-0.58 2.03e-5 
14 rs8016621 A Intronic SALL2 Male 0.252 0.14-0.46 5.91e-6 
5 rs2894967 C 5’UTR TENT4A Female 2.173 1.56-2.90 4.77e-6 
9 rs10819610 T Intronic NCS1 Female 0.514 0.39-0.67 1.55e-6 
14 rs7152005 T Intronic DPF3 Female 2.13 1.66-2.90 1.52e-6 
21 rs2150367 T Intronic LINC02246 Female 0.502 0.38-0.67 1.56e-6 
*OR: Odds ratio; 95% CI: 95% confidence interval 
For the X chromosome specific association testing a sex-stratified test was conducted and the results 
were then combined using Stouffers method, which provided a good fit between expected and 
observed p-values (QQ-plot Figure 4.3) (115,302). The simpleM method indicated that of the 20939 
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X-linked variants 17600 explained 95% of the variance in the data resulting in a significance threshold 
of 2.8e-6 (0.05/17600). No statistically significant associations with TB susceptibility were identified in 
either sex-stratified or the combined analysis (Table 4.3 and Figure 4.3). The lowest p-value 
association for the X-linked combined (p-value = 2.62e-5) and females (OR = 1.83, p-value = 1.06e-4) 
only analysis was the same variant, rs768568, located in the TBL1X gene. For the males the top hit 
was rs12011358 (OR = 0.37, p-value = 1.25e-4) located in the MTND6P12 gene. Both of these genes 
have not been previously associated with TB susceptibility and MTND6P12 is a pseudogene with 
unknown expression patterns or function. Variants in TBL1X have been shown to influence prostate 
cancer (311) and central hypothyroidism (312) susceptibility. TBL1X is a regulator of nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-kB) and is thus involved in the immune system 
which could impact TB susceptibility.  
The method of modelling X chromosome inactivation states, developed by Wang et al. (305), was 
also incorporated into the X-linked association testing, but no significant observations were observed. 
Although the p-values were generally lower than for the Stouffer method, the QQ-plot revealed that 
including estimations of X chromosome inactivation states inflated the p-values and increased the 
chance of type 1 errors and these results were therefore discounted (Table S4.1 and Figure S4.3). 
Table 4.3: Most significant X-linked associations, using Stouffers method to combine p-values. 
Chr 
SNP 
(Location) A1 Gene 
Male Female P 
combined OR* 95CI* P OR* 95CI* P 
X rs768568 
(Intron) 
C TBL1X 1.69 1.0-
2.86 
5.07 e-2 1.83 1.35-
2.49 
1.06 e-4 2.62e-5 
X rs12011358 
(5’UTR) 
T MTND6P12 0.37 0.22-
0.62 
1.25 e-4 0.72 0.53-
0.96 
2.72 e-2 2.82e-5 
X rs930631 
(3’UTR) 
T MIR514A1 0.48 0.29-
0.79 
3.66 e-3 0.67 0.49-
0.90 
7.74 e-3 8.94e-5 
*OR: Odds ratio; 95% CI: 95% confidence interval 
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Figure 4.2: Manhattan plot (above) for X-linked associations with significance threshold indicated 
(red line). QQ-plot (below) shows good correlation between expected and observed p-values.  
The sex differentiation test did not result in any significant associations (Table 4.4), with the 
association with the lowest p-value was located in a pseudogene, RNU6-974P (p-value = 8.33e-5). 
The second lowest p-value was for a variant upstream of the SRPX (p-value = 2.18e-4) gene which 
has previously been shown to have a tumour suppressor function in prostate carcinomas (313). 
Whether these variants are associated with TB susceptibility or influence sex-bias is unclear, but the 
vastly opposite effects between the sexes are noteworthy. When comparing the OR for the sex 
differentiation test it is clear that variants can have major sex specific effects again highlighting the 
need for sex-stratified analysis (Table 4.4).  
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Table 4.4: Sex-differentiation analysis results.  
Chr SNP A1 Location Gene 
Male Female 
P-Diff OR* 95CI* P OR* 95CI* P 
X rs145407087 C 3’UTR 
RNU6-
974P 
0.427 0.12-
1.54 
0.193 7.147 1.95-
26.19 
0.003 8.33e-5 
X rs5917743 C 5’UTR SRPX 
0.300 0.05-
1.89 
0.203 15.04 1.81-
124.7 
0.012 2.18e-4 
X rs1337567 C 5’UTR DIAPH2 
1.45 0.88-
2.39 
0.146 0.571 0.42-
0.78 
3.49e-4 6.73e-4 
*OR: Odds ratio; 95% CI: 95% confidence interval 
4.6.2.2 Gene based 
The X chromosome gene-based analysis, in which 1105 X-linked genes were analysed did not show 
any significant associations using a Bonferroni-adjusted significance threshold of 4.5e-5 (Table 4.5). 
The top hit for the combined analysis was in the chromosome X open reading frame 51B (CXorf51B) 
(p-value = =1.28e-4) coding for an uncharacterised protein (LOC100133053). The top hit for males 
was in an RNA coding region that interacts with Piwi proteins (DQ590189.1, p-value = 1.7e-3), a 
subfamily of Argonaute proteins. While Piwi proteins are involved in germline stem cell maintenance 
and meiosis the function of the Piwi interacting RNA molecules are unknown (314). For females the 
top hit was the ARMCX1 gene (p-value = 6.07e-4) a tumour suppressor gene involved in cell 
proliferation and apoptosis of breast cancer cells. While this gene has not been previously implicated 
in TB susceptibility, M. tuberculosis has been shown to affect apoptosis pathways in order to evade 
the host immune response, suggesting that ARMCX1 could affect TB susceptibility (315). While not 
significant the analysis again reveals strong sex specific effects and the sex-stratified and combined 
analysis gave three different results (Table 4.5). 
Table 4.5: X chromosome gene-based association results. 
Chr Gene Group P-value 
X CXorf51B Combined 1.28e-4 
X DQ580189.1 Male 1.7e-3 
X ARMCX1 Female 6.07e-4 
 
4.6.2.3 Interaction analysis 
A genome-wide interaction analysis was performed using the software Cassie. In total 1893973105 
interactions were analysed and following a Bonferroni correction for the number of interactions 
performed the significance threshold was set to 2.6e-11. For the joint effects model, 18 interactions 
passed the significance threshold (Table S4.2). The interaction with lowest p-value was between 
rs1823897 upstream of the ARSF gene and rs7064174 in the FRMPD4 gene (p-value = 7.23e-14), two 
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genes for which not much information is available, and it is unclear how they could be involved in TB 
susceptibility. The top 450 associations from the joint effects model were then retested using logistic 
regression and the same covariates as the SNP based association testing. No significant interactions 
(threshold of 2.6e-11) were observed in the logistic regression model (Table 4.6), but as Bonferroni 
correction is very conservative the top interactions should still be considered as they reach the 
significance level for SNP based GWAS.  
Among the top hits in the logistic regression analysis (Table 4.6) some could impact TB susceptibility 
as they are involved in immune functions. The top hit interaction was between rs2631914 
(LINCO2153), which is upregulated in people with major depressive disorder (316) and rs8067702 
(RTN4RL1), previously associated with congenital heart disease, microcephaly and mild intellectual 
disability (317). While this interaction is not very informative in the context of TB three other 
interactions were identified that could impact TB susceptibility (Table 4.6).  
The first interaction of interest is between RNF125 gene (rs35996537) and URI1 (rs1118924), 
involved in downregulation of CD4+/CD38− T-cells and PBMCs in HIV-1 positive individuals and NF-
kB/CSN2/Snail pathway, activated by TNFα respectively (318,319). Second the interaction between 
rs386560079 (ATP2C1), which is involved in regulation of intracellular Ca2+/Mn2+ concentrations 
through the Golgi apparatus (320) and rs6498130 (CIITA). Variants in the CIITA gene reduce the 
expression of MHC class II proteins and receptors resulting in an immune privilege phenotype (321). 
The final interaction of interest is between rs12286374 (NTM), which is mainly expressed in the brain 
and promotes neurite outgrowth and adhesion (322) and rs2040739 (RNF126) a ring type E3 ligase 
involved in the Protein B kinase pathway which has been previously implicated in glucose metabolism, 
apoptosis, cell proliferation and transcription (323). While none of these genes have previously been 
implicated in TB susceptibility the fact that some of them are involved in immune functions suggests 
a role in TB susceptibility 
Table 4.6: Logistic regression interaction analysis with covariate adjustment.  
Chr1 SNP1 Location Gene1 Chr2 SNP2 Location Gene2 P 
8 rs2631914 5’UTR LINC02153 17 rs8067702 3’UTR RTN4RL1 1.73e-9 
2 rs6756958 Intronic GALNT5 4 rs201376793 5’UTR RNU6ATAC
13P 
1.92e-9 
4 rs882773 5’UTR HMX1 18 rs9303903 3’UTR METTL4 5.76e-9 
12 rs1798087 5’UTR TSPAN1 13 rs2091337 3’UTR LOC105370
290 
5.8e-9 
1 rs7517749 Intronic RGS7 23 rs5907910 3’UTR SPANXA2-
OT1 
1.14e-8 
7 rs757808 5’UTR KIAA0087 8 rs12676973 3’UTR  FUT10 1.77e-8 
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Chr1 SNP1 Location Gene1 Chr2 SNP2 Location Gene2 P 
4 rs1919904 5’UTR TMPRSS11
E 
11 rs10769029 Intronic ALX4 1.95e-8 
5 rs10040477 5’UTR LINC02148 12 rs1918193 intronic SYT1 2.82e-8 
1 rs6694239 5’UTR TNR 2 rs985256 intronic SPATS2L 3.22e-8 
12 rs7975477 Intronic MGAT4C 20 rs6123951 intronic PHACTR3 3.29e-8 
18 rs35996537 3’UTR RNF125 19 rs1118924 Intronic URI1 3.82e-8 
5 rs10040477 5’UTR LINC02148 12 rs1918195 Intronic SYT1 3.87e-8 
3 rs386560079 Intron ATP2C1 16 rs6498130 Intronic CIITA 3.94e-8 
11 rs4237591 3’UTR CNTN5 14 rs11850085 Intronic SLC8A3 4.54e-8 
1 rs1411276 Intronic TGFBR3 4 rs1972127 Intronic PRKG2 4.86e-8 
12 rs7962106 5’UTR AVPR1A 18 rs200219001 Intronic LDLRAD4 4.94e-8 
14 rs242402 Intronic PELI2 19 rs2459744 5’UTR SBK3 5.22e-8 
11 rs12286374 5’UTR NTM 19 rs2040739 Intronic RNF126 5.49e-8 
 
4.7 Discussion 
In this GWAS we investigated TB susceptibility in the admixed SAC population, with a specific focus 
on sex-bias and the X chromosome. A sex-stratified QC protocol was applied to the data in order to 
conserve inherent differences between the sexes and all statistical analysis were conducted in a sex-
stratified and combined dataset in order to fully assess the impact of sex on TB susceptibility and the 
male sex-bias it presents with. We found no significant associations on the autosome or X 
chromosome for both the sex-stratified and combined SNP and gene-based association testing. A 
few significant interactions were identified, but the impact of these on TB susceptibility is unclear and 
will require further investigation to validate and functionally verify. 
For the combined autosomal SNP based association testing the only potential variant of interest is 
rs17410035 located in the DROSHA gene (Table 4.2) which is potentially involved in miRNA 
biogenesis and could impact TB susceptibility if immune related regulatory miRNA is affected. For the 
X-linked association testing the association with the lowest p-value in males was in an uninformative 
pseudogene, while the female and combined analysis revealed the same variant, rs768568 located 
in the TBL1X gene (Table 4.3). The TBL1X protein has been shown to be a co-activator of NF-kB 
mediated transcription of cytokine coding genes, but the mechanism of activation is unclear (311). 
NF-kB is a vital component of the proinflammatory signalling pathway and is involved in multiple 
immune pathways including TLRs (324), which have previously been shown to influence TB 
susceptibility (291). Based on this one could extrapolate that variants in the TBL1X gene could affect 
activation and proinflammatory signalling of NF-kB, which could have a direct effect on the immune 
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system and thus TB susceptibility. The direction of effect for this variant was the same in males and 
females (Table 4.3), but was less significant in males probably due to loss of power when analysing 
haploid genotypes. For the variants identified in the sex differentiated analysis it is unclear how they 
could influence TB susceptibility as the top hit is located in a pseudogene. However, the sex 
differentiated test did reveal just how big the difference in effects can be between the sexes for a 
specific variant (Table 4.4). If these variants with opposite effects are not analysed in a sex-stratified 
way then the effects would cancel each other out and any information on sex specific effects would 
be lost. The X-linked gene-based association test revealed no significant associations despite having 
more power than the SNP based association testing. A possible reason for this could be that 
Bonferroni correction was used and as this is very conservative possible associations could have 
been missed. When looking at the associations with the lowest p-value (Table 4.5) however it is 
unclear how the identified genes could be implicated in TB susceptibility.  
The joint effects interaction analysis revealed several significant interactions, but as association 
results have been previously shown to be severely influenced by admixture (325) only the results for 
the logistic regression analysis will be discussed here. A few variants were identified in the logistic 
interaction analysis that could impact TB susceptibility (Table 4.6). URI1 (rs1118924) is activated by 
TNFα and is involved in the NF-kB/CSN2/Snail pathway, CIITA (rs6498130) impacts expression of 
MHC class II proteins and receptors and rs35996537 (RNF125) and rs2040739 (RNF126) are both 
E3 ubiquitin ligase proteins which affect a multitude of cellular functions, such as apoptosis (323) and 
protein degradation (326). NF-kB, TNFα, MHC class II, E3 ligases, apoptosis and T-cells have all 
been implicated in TB susceptibility and could collectively contribute by influencing the immune 
response (315,326–332). As TB is a complex disease all potential influential factors need to be 
considered and as such the interaction analysis cannot be ignored. Shortcomings of the interaction 
analysis are that they are very computationally intensive and suffer from a massive multiple test 
correction burden. Future research should thus focus on ways to prioritise variants for interaction 
analysis to decrease computation time as well as have sufficient sample size to minimise multiple test 
correction burden.  
A previous GWAS in the SAC population found a significant association with TB susceptibility in the 
WT1 gene (rs2057178, OR = 0.62, p-value = 2.71e-6) (333). This association did not reach genome-
wide significance in our study (OR = 0.75, p-value = 0.049). At the time of the GWAS by Chimusa et 
al. (333) there were few African and KhoeSan (only 6 KhoeSan) individuals in the reference data used 
for imputation and the accuracy of imputation in this population was not known. As the identified 
variant (rs2057178) was imputed into the data it should have been validated in the SAC population 
using an appropriate genotyping approach. Secondly although the variant reached a significance 
threshold for the number of variants tested it did not reach genome wide significance threshold of 
5.0e-8 (307). Finally, the GWAS performed by Chimusa et al. (333) only contained 91 control 
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individuals compared to 642 cases, which could affect the power of the study. Chimusa et al. (333) 
were unable to replicate previous associations identified in the X-linked TLR8 gene (295). The two 
TLR8 variants in our data, rs3764880 (OR = 1.73, p-value = 3.1e-4) and rs3761624 (OR = 1.70, p-
value = 3.94e-4) also did not show significant associations. While the haploid genotypes in males 
contributes to this, a second influential factor could be admixture. Chimusa et al. (333) did not perform 
X chromosome specific admixture analysis, which could affect association testing of X-linked genes. 
Furthermore, only six KhoeSan reference individuals were available, which could affect the accuracy 
of admixture inference and severely affect the results. For our study 307 KhoeSan individuals were 
available, improving the admixture inference and could explain why stronger effects (higher OR) were 
detected for the TLR8 variants when compared to Chimusa et al. (333). It is also important to note 
that using global ancestry components as covariates does not correct for ancestry at any specific 
locus and as a result each locus in this population could have up to five different ancestries. This 
could greatly reduce power and contribute to the lack of replication between studies. In order to 
address this, future studies could incorporate local ancestry inference into the analysis in order to 
determine the number of ancestries at a locus of interest. Other candidate genes identified in previous 
GWAS studies were also separately analysed here, but associations did not replicate (Online 
supplementary material).  
We did not find any significant associations with TB susceptibility but highlight the need for sex-
stratified analysis. Closer inspection of the data revealed that a large number of SNPs with opposite 
direction of effects for not only the X chromosome, but the autosome too. Sex specific effects has 
previously been reported for autosomal variants associated with pulmonary function in asthma (334). 
In the SAC population these opposite effects have previously been observed for X-linked variants in 
the TLR8 gene (138) and the same is observed in this study. Sex-stratified analysis should therefore 
be included in association studies and incorporated in the study design. This can be done by keeping 
the male to female ratio balanced in the cases and controls. It would also be prudent to do the power 
calculation for the males and females separately. This will ensure sufficient power for sex-stratified 
analysis and could elucidate informative sex specific effects. This study was done in a 5-way admixed 
population. As was observed for the interaction analysis including admixture components significantly 
changes the association results. Furthermore it was observed (unpublished results) that the ancestral 
distribution between the X chromosome and autosome are different (Figure 4.1), which is an indication 
of sex-biased admixture (279,286) and highlights the importance of including X chromosome 
admixture components for X-linked and sex-bias analysis. It is important to note here that the 
ancestral components in the SAC present with a very wide range (Figure 4.2) and all this variability 
could affect the power of association studies. It is therefore desirable to increase the sample size 
when analysing admixed individuals. Alternatively, a meta-analysis can be conducted, including data 
from all 5 ancestral populations, or local ancestry inference could be included in the analysis. 
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In conclusion, while no significant associations were identified this study shows the importance of 
conducting sex-stratified analysis. This analysis should be incorporated during the study design phase 
to ensure sufficient power and allow the inclusion of covariates with sex specific effects (in this case 
admixture components). The sex-stratified analysis revealed that the effect of certain variants can 
differ between males and females, not only for the X chromosome but also for the autosome. TB is a 
complex disease with most genetic associations that do not replicate across different populations, 
which complicates the elucidation of the genetic impact on disease susceptibility. By including sex-
stratified analysis and identifying sex specific effects and the cause for the male bias we can adjust 
treatment according to sex and potentially improve treatment outcome and survival.  
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4.11 Supplementary material 
 
Figure S4.1: Flow diagram of data QC and association testing. 
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Figure S4.2: Manhattan plot and QQ plot for sex-stratified and combined analysis on the Autosome. 
Red line indicates significance threshold (5e-8). 
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Figure S4.3: Manhattan and QQ-plot for X-linked SNP association testing including modelling for 
inactivation states, the red line indicates significance threshold of 2.8e-6. QQ-plot indicates inflated 
p-values and potential increase in type 1 errors. 
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Table S4.1: Most significant results for X-linked SNP association testing including modelling of X 
chromosome inactivation states. 
SNP Gene Location Model OR 95CI-
L 
95CI-
H 
p 
rs768568 TBL1X Intron Escape_of_XCI 0.56 0.43 0.72 1.17e-5 
rs6631824 DMD 5'UTR Random_XCI 0.69 0.59 0.82 2.07e-5 
rs12011358 NLGN4X 3'UTR Skewed_XCI_to_risk_allele 1.51 1.25 1.82 2.14e-5 
rs930631 MIR506 3'UTR Random_XCI 1.41 1.20 1.65 3.19e-5 
rs176024 MAGEC3 5'UTR Escape_of_XCI 0.56 0.43 0.74 5.45e-5 
23:9959944 SHROOM2 5'UTR Skewed_XCI_to_risk_allele 0.21 0.07 0.49 1.32e-3 
rs386827412 GRIA3 Intron Skewed_XCI_to_risk_allele 0.64 0.51 0.80 8.35e-5 
rs17340554 DMD Intron Skewed_XCI_to_risk_allele 0.35 0.19 0.61 3.67e-4 
rs5933749 TBL1X Intron Escape_of_XCI 1.72 1.31 2.27 1.03e-4 
 
Table S4.2: Results for genome wide interaction analysis using the joint effects model and no 
adjustment for covariates. 
Chr1 SNP1 Gene1 Chr2 SNP2 Gene2 P-value 
23 rs1823897 ↑* ARSF 23 rs7064174 FRMPD4 7.23e-14  
23 rs426247 ↑ ARSE 23 rs68046754 PCDH11X 1.96e-12 
5 rs2112508 LOC107986418 10 rs1194709 ↑ RPL31P44 2.81e-12 
7 rs1347075 LOC107986770 8 rs958374 ↑ LOC157273 3.49e-12 
23 rs5991619 ↓* MAOA 23 rs73535318 RNU6-555P 5.87e-12 
13 rs7991005 GPC6 16 rs2287072 LPCAT2 5.95e-12 
23 Rs11094800 ↓ NLGN4X 23 rs68046754 PCDH11X 7.20e-12 
5 rs7341174 LINC02147 12 rs1918191 SYT1 7.63e-12 
23 rs68046754 PCDH11X 23 rs6528958 ↓ MAGEC2 8.37e-12 
1 rs6694239 ↓ PAPPA2 2 rs985256 SPATS2L 1.12e-11 
23 rs4824843 ↑ FUNDC1 23 rs58762927 LOC107986770 1.29e-11 
23 rs2170314 ↑ DIAPH2 23 rs4633188 ↑ DIAPH2 1.32e-11 
5 rs2112508 LOC107986418 10 rs1194716 ↑ RPL31P44 1.33e-11 
23 rs5972637 DMD 23 rs73535318 RNY6-555P 1.65e-11 
23 rs1352015 EDA2R 23 rs68046754 PCDH11X 1.75e-11 
23 rs5916341 NLGN4X 23 rs68046754 PCDH11X 2.50e-11 
23 rs3072699 NLGN4X 23 rs68046754 PCDH11X 2.50e-11 
23 rs1823897 ↑ ARSE 23 rs7053176 ↑ CXCR3 2.59e-11 
↑*: Upstream 5’UTR; ↓*: Downstream 3’UTR
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5.1 Abstract 
Genotype imputation is a powerful tool for increasing statistical power in an association analysis. 
Meta-analysis of multiple study datasets also requires a substantial overlap of SNPs for a successful 
association analysis, which can be achieved by imputation. Quality of imputed datasets is largely 
dependent on the software used, as well as the reference populations chosen. The accuracy of 
imputation of available reference populations has not been tested for the five-way admixed South 
African Coloured (SAC) population. In this study, five methods were tested for imputation accuracy 
and quality, comprising three imputation software packages and three reference panels. We show 
that the African Genome Resource is the best reference panel for the SAC population, with 
implementation via the freely accessible Sanger Imputation Server.  
5.2 Introduction 
Over the past decade, genotyping technologies for genome-wide association studies (GWAS) have 
allowed for extensive and rapid genotyping of common variants (335–337). Commercial single 
nucleotide polymorphism (SNP) genotyping arrays contain between 300 000 and 2.5 million markers, 
but none have complete coverage of the human genome. Genotype imputation can be used to 
improve both coverage and power of a GWAS by inferring the alleles of un-genotyped SNPs based 
on the linkage disequilibrium (LD) patterns derived from directly genotyped markers and comparing 
them to a suitable reference population (338–340). These imputed variants can then be used for 
association testing, to improve fine-mapping of a target region, or to conduct a meta-analysis.  
Meta-analysis is a powerful and commonly used technique, but if the study data were generated using 
different platforms, there may be a reduction in statistical power due to minimal overlap between the 
genotyped markers. To overcome this reduction in power, imputation may be used to increase the 
marker overlap between datasets, thereby improving the power of a meta-analysis (90,338,341,342).  
Imputation is dependent on the adequate matching of haplotypes based on LD and thus it is essential 
that the reference population is genetically similar to the population being imputed. Numerous 
reference datasets are freely available online and can be used for imputation via suitable imputation 
software. These include amongst others, the 1000 Genomes phase 3 data (1000G, 10), the Human 
Genome Diversity Project (82), Haplotype Reference Consortium (HRC, 12) and the HapMap 
consortium (84). Most of the above-mentioned reference panels focus mainly on the European 
population and representation of African populations and admixed populations containing African 
ancestry is limited.  
African and admixed populations are more heterogeneous in their haplotype block structure and, as 
such, would benefit from a larger reference dataset incorporating more genetic diversity (337). 
Reference datasets of this nature would increase the chances that an observed haplotype is present 
in the reference data, thereby greatly improving the imputation accuracy for African and admixed 
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individuals with African ancestry. Fortunately, recent years have seen a substantial increase in the 
representation of African populations in the 1000G data (81) and additional databases focusing on 
representing African populations have been established. The Consortium on Asthma among African 
ancestry populations in the Americas (CAAPA, Mathias et al., 2016) is available for download from 
dbGap with Accession ID:phs001123.v1.p1 and the African Genome variation project (AGVP) (89) as 
well as the African Genome Resource (AGR) (not publicly available7) are three resources which have 
recently become a viable option for accurate imputation of African populations. 
Apart from choice of reference panel, the software used also affects the imputation accuracy (341). 
Many imputation software packages are freely available and have been previously tested and 
validated for accuracy, including Impute2 (80), Beagle (343), MaCH, MaCH-Minimac and MaCH-
Admix (344). These imputation software packages were evaluated in African and African-American 
populations using different reference panels and produced varying degrees of imputation quality and 
accuracy (341,344).  
Huang et al. (345) tested imputation accuracy in 29 populations using the HapMap reference and 
showed that the highest imputation accuracy was achieved for European populations, followed by 
East-Asian, Central- and South-Asian, American, Oceanian, Middle-Eastern and African populations. 
An additional finding from this study was that combining multiple reference populations resulted in 
improved imputation accuracy for any population analysed (345). While more appropriate reference 
panels are now available, which would increase the accuracy of imputation in African individuals, 
these results indicate that there are difficulties when imputing populations for which there is a limited 
number of reference individuals.  
Imputation accuracy has previously been assessed for African populations (341,344,345) and for 
populations with two- or three-way admixture, with results reaching over 75% accuracy (346). In the 
present study, we assessed the accuracy of imputation in the five-way admixed South African 
Coloured (SAC) population. The SAC population contains genetic contributions from Bantu-speaking 
Africans, KhoeSan, Europeans, and South- and East-Asians (86,87). While imputation in this 
population has been conducted previously and the resulting data used for association analyses (333), 
the accuracy of imputation in this highly admixed population is yet to be evaluated.  
Here we tested the quality and accuracy of imputation in the SAC population using different imputation 
software and reference panels and show that the Sanger Imputation Server using the AGR reference 
panel produced the highest quality and accuracy in imputed data. An in-house method using 
IMPUTE2 and 1000G reference panel imputed more variants than Sanger (AGR) but at a slightly 
reduced quality and accuracy.  
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5.3 Methods 
5.3.1 SAC data 
Two sources of data for the SAC cohort were available, namely genotypes obtained using the 
Affymetrix 500k array containing 500 000 SNP markers (Affymetrix, California, USA) and the Illumina 
(Illumina, California, USA) multi-ethnic genotyping array (MEGA) with 1.7 million markers. Approval 
was obtained from the Health Research Ethics Committee of Stellenbosch University (project 
registration number S17/01/013, S17/02/037 and 95/072) before participant recruitment and written 
informed consent was obtained from all study participants prior to blood collection. 
Genotype datum obtained using the MEGA array was subjected to iterative quality control (QC) using 
PLINK v1.9 (120,304) as previously described (281), with the exception of related individuals not 
being removed. Individuals with more than 10% missing information and SNPs with more than 2% 
missingness were removed, as well as any variants with a minor allele frequency (MAF) below 5% as 
well as loci with excessive heterozygosity.  
These QC steps were iterated until no additional variants or individuals were removed, and concluded 
with a sex-concordance check to remove individuals with incorrect sex information. Genotype 
Harmoniser version 1.4.15 (347) was used to strand align the two datasets to the 1000 Genomes 
Phase 3 reference panel (human genome build 37, (81)), update SNP IDs and remove any variants 
not in the reference panel. For the strand alignment a minimum LD value of 0.3 with at least three 
flanking variants was required for alignment. A secondary MAF alignment was also used at a 
threshold of 5%. Finally, the minimum posterior probability was set to 0.4.  
5.3.2 Phasing and imputation 
Three different methods were used for phasing and imputation to assess which performed best for 
our admixed population. The first was an in-house method where the Affymetrix data (PLINK files) 
were phased with SHAPEIT v2 (348), using the default effective population size of 15 000. Imputation 
was then done using IMPUTE2 v2.3.2 (80) and the 1000G Phase 3 reference panel (81), with default 
parameters except for the effective population size, which again was set to 15 000.  
The second method made use of the Sanger Imputation server (SIS8). Genotypes from the Affymetrix 
500k array in PLINK file format were converted to Variant Call Format (VCF) using PLINK v1.9 and 
then uploaded to the server where phasing was performed using SHAPEITv2.r790 (348) followed by 
imputation using the Positional Burrows-Wheeler Transformation (PBWT) algorithm (349). Imputation 
was done in two separate runs: the first run used the 1000G Phase 3 reference panel for imputation, 
and the second run made use of the African Genome Resource panel.  
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The third method made use of the Michigan Imputation server (MIS, (350)). PLINK files were 
converted to VCF using PLINK v1.9 and uploaded to the server for two imputation runs, both of which 
were run on the QC and imputation mode. SHAPEITv2.r790 was used for haplotype phasing in both 
runs followed by imputation using the Minimac3 algorithm (350). For the first run the mixed population 
option was used for the QC and haplotype phasing was done followed by imputation with the 1000G 
Phase 3 reference panel. For the second imputation run, it was mandatory for the African-American 
population to be selected for QC when imputing with the CAAPA reference panel. 
Although haplotype pre-phasing has been shown to decrease imputation accuracy slightly it was used 
in this study for consistency between the methods (the Michigan server did not have an option to not 
phase data) and to increase the speed of imputation (80).  
For all imputation runs, the reference panels included all available populations since using an all-
inclusive reference panel is known to improve imputation accuracy (345). Of the five variations of 
imputation performed, only the MIS (CAAPA) run was incapable of performing imputation on the X 
chromosome. Results for the X chromosome have however been included for the other four 
imputation runs since the accuracy of X-linked imputation has not been evaluated previously. 
5.3.3 QC of imputed data 
Imputed data were returned from the imputation software in one of two formats: either in the form of 
a VCF file, or in Impute2 (gen/sample) format and based on the format, one of two QC procedures 
was employed to convert the imputed data from genotype probabilities to actual genotypes. Data 
output from the two procedures were compared and showed complete overlap and can thus be used 
interchangeably. 
Procedure 1: For the in-house imputation done using Impute2, a gen/sample output file was obtained 
and converted to a PLINK file using GTOOL9 version 0.7.5. R version 3.2.4 was used to identify 
INDELS, which were then removed using GTOOL (142). This was performed in order to more 
accurately assign SNP IDs and allele information when genotypes were called using GTOOL. The 
genotype calling threshold was set to 0.7, which was determined to have the best ratio of imputation 
accuracy and number of imputed variants (Figure S5.1). Once genotypes were called, the resulting 
ped/map PLINK files were converted to bed/bim/fam PLINK files and all variants with no-call alleles 
were removed.  
Procedure 2: For the imputation done using the two online servers, VCF files were returned. The VCF 
files were converted to PLINK ped/map files using a genotype calling threshold of 0.7 (PLINK 
command: --vcf-min-gp command) and coding all no-call alleles as N (PLINK command: --output-
                                               
9 http://www.well.ox.ac.uk/~cfreeman/software/gwas/gtool.html 
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missing-genotype N). INDELS and SNPs with no-call alleles were removed and the files were 
converted to PLINK bed format (bed/bim/fam).  
5.3.4 Imputation quality and accuracy 
To assess imputation quality, the INFO score (in the case of IMPUTE2) and the comparable r-squared 
value (for PBWT and Minimac3) were used. These values range from 0 to 1, where a higher value 
indicates increased quality of an imputed SNP. Mean INFO score and r-squared values were plotted 
against MAF in order to determine how quality was affected by MAF and to assess which imputation 
method had the best quality at a given MAF. 
Imputation accuracy was assessed by extracting the overlapping individuals from the MEGA and 
imputed Affymetrix data and using PLINK to remove any variants that overlapped between the two 
platforms prior to imputation. The analysis was performed per chromosome and for each SNP the 
alleles were compared between the imputed Affymetrix data and the MEGA data. If both alleles of a 
SNP matched it would be considered a complete match (or a flip match if alleles were correct but 
strand swopped). If only one allele matched it was considered a half match and if no alleles matched 
it was considered a no-match. For each chromosome the total number of imputed variants was 
recorded and their distribution by MAF was plotted to determine how the number of variants correlated 
with MAF between the different imputation methods.  
To determine the imputation accuracy, the SNP overlap between the MEGA and imputed Affymetrix 
data was assessed. Within this overlap the number of SNPs that were complete-, flip-, half- or 
non-matched were recorded along with their average INFO score or r-squared value. Since SNPs 
that are flipped can be flipped to align a reference, or a different dataset if a meta-analysis is planned, 
the flipped SNPs were considered matches for the purposes of calculating imputation accuracy. 
Accuracy was calculated by comparing the proportion of SNPs in the overlap that were complete (or 
flipped) matches to the number of overlapping SNPs. This gave an indication of accuracy and error 
rate within the overlapping region and should be a good indication of overall imputation accuracy. 
These calculations were performed for the autosomes and the X chromosome separately in order to 
determine how accurately and with what quality the imputation software imputed X-linked variants 
compared to autosomal variants.  
5.4 Results 
5.4.1 Genotyping data 
After QC and strand alignment there were 919 individuals and 239 612 variants with a genotyping 
rate of 99.39% in the Affymetrix 500k dataset, and 771 Individuals with 1 491 347 variants in the 
MEGA data with a genotyping rate of 99.43%. A total of 325 individuals were genotyped on both the 
Affymetrix and MEGA array and 43 140 SNP markers overlapped between the two platforms. 
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Overlapping individuals were extracted and overlapping variants (prior to imputation) were removed 
from both datasets. 
5.4.2 Imputation 
The two imputation methods that performed best were the in-house IMPUTE2 with 1000G reference 
panel and the Sanger imputation server with the AGR reference panel. The in-house method had the 
most imputed variants across both the autosomes (60 438 387) and X chromosome (2 574 793), 
followed by SIS (AGR) (52 088 766 autosomal and 1 638 163 X-linked variants), while the SIS with 
1000G reference panel had slightly fewer imputed variants than with the AGR panel (50418390 
autosomal and 1679254 X-linked variants). The Michigan imputation server had only about half as 
many imputed variants as the other methods, for either reference panel (Table 5.1). The number of 
imputed variants that did not reach the genotype calling threshold (0.7) was lowest in the in-house 
method followed by the Michigan server results, and SIS (1000G) and SIS (AGR) had the highest 
percentage of variants not reaching genotype calling threshold (Table 5.1). When imputed Affymetrix 
variants were compared to the MEGA genotypes, the SIS (AGR) data had the highest accuracy (within 
the overlapping region) on both the autosomes (89.29%) and X chromosome (90.18%). The 
imputation accuracy for the in-house and SIS (1000G) method was very similar, with the in-house 
method having a slightly lower genome wide error rate. The accuracy of the Michigan server was 
good on the autosomes (~83%) but lacking for the X chromosome (~70%) (Table 5.2). The SIS (AGR) 
imputed the least X-linked variants, but at the highest accuracy, whereas the in-house method had 
twice as many X-linked variants as Sanger with only a 2.48% drop in accuracy (Table 5.2 and 5.3).  
Table 5.1: Number of imputed variants and variants overlapping with MEGA as well as the 
percentage of calls that did not reach the genotype calling threshold (0.7). Imputed number of SNPs 
is given in millions and Overlapping number is given per ten thousand. 
Method Reference 
Autosomes X chromosome % No 
calls Imputed1 Overlap2 Imputed1 Overlap2 
In-house 1000G 57.8 72.1 2.5 1.6 25.46 
SIS 
1000G 48.7 46.7 1.7 1.0 35.89 
AGR 50.5 60.5 1.6 1.5 44.18 
MIS 
1000G 28.6 47.7 1.3 1.1 35.22 
CAAPA 16.9 34.3 NA NA 43.40 
1Number of SNPs in millions 
2Number of SNPs per ten thousand 
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Table 5.2: Genome wide error rate and accuracy of imputation on the autosomes and X 
chromosome.  
Method Reference 
Accuracy in overlap (%) GW Error rate 
in overlap (%) Autosomes 
X 
chromosome 
In-house 1000G 88.00 87.70 12.00 
SIS 1000G 87.15 88.23 12.85 
SIS AGR 89.29 90.18 10.70 
MIS 1000G 83.26 69.87 16.74 
MIS CAAPA 62.45 NA 37.55 
 
Table 5.3: Number of SNPs and accompanying average info score for the three categories, within 
the MEGA overlapping region. 
Method Reference 
Autosomes X chromosome 
Total Half No Total Half No 
In-
house 
1000G 6321 0.78 381 0.36 481 0.89 351 0.73 2.71 0.37 2.11 0.83 
SIS 
1000G 407 0.79 25 0.46 35 0.87 8.9 0.8 0.5 0.56 0.7 0.88 
AGR 541 0.79 23 0.5 42 0.89 12.9 0.83 0.6 0.6 0.8 0.89 
MIS 
1000G 400 0.69 45 0.11 33 0.83 19.5 0.57 7.1 0.08 1.3 0.70 
CAAPA 214 0.68 105 0.03 24 0.76 NA 
1Number of SNPs in thousands  
For the autosomes and X chromosome, the SIS (AGR) had the best imputation quality across all MAF 
ranges, closely followed by the in-house method where quality was second to SIS (1000G) only for 
low MAF (0-1%) variants on the X chromosome (Figure 5.1). The Michigan server produced the lowest 
quality imputation (Figure 5.1 and Table 5.3). The mean quality score was comparable across all 
autosomal chromosomes and thus only chromosome 1 is shown to represent the autosome and for 
comparison to the X chromosome (Figure 5.1). Figure 5.2 confirms that SIS (AGR) and the in-house 
method had the best imputation quality since more SNPs were imputed at high quality for both 
autosome and X chromosome. Since SIS (AGR) has the largest number of imputed genotypes not 
reaching the calling threshold a trade-off between quality and number of variants exists between SIS 
(AGR) and the in-house method.  
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Figure 5.1: Mean quality score for all variants in a certain MAF range for all imputed datasets. In-
house (IH), Sanger Imputation server (SIS) and Michigan Imputation Server (MIS).  
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Figure 5.2: Distribution of the number of imputed SNPs by quality score for A) chromosome 1 and 
B) the X chromosome. 
Stellenbosch University  https://scholar.sun.ac.za
73 
 
5.5 Discussion 
Imputation accuracy was previously evaluated in African and three-way admixed populations, but we 
have performed the first evaluation in a five-way admixed population. The imputation accuracy in 
African-American individuals (considered to be three-way admixed) ranges from 78% (340) to 89% 
(80). Bantu-speaking Southern African individuals have been imputed with an accuracy of about 95% 
and even African San individuals had an imputation accuracy of 89% (345). In the present study, the 
SIS (AGR) and the in-house imputation method had similar accuracies (89% and 88% respectively, 
Table 5.2) compared to previous results from African and admixed populations. It should however be 
noted, that the clear majority of non-matching variants were ambiguous (Imputed genotype A/T and 
MEGA genotype G/C, or vice versa) and the majority of half-matched variants were imputed as 
monomorphic (data not shown). These ambiguous variants were imputed at high quality (Table 5.3) 
and were not removed when filtering on quality score but could be removed or aligned to a reference 
allele using appropriate software (such as Genotype Harmonizer). However, removal of these 
ambiguous variants is not mandatory. When analysing a single dataset, the ambiguous variants of 
interest can be compared to a relevant reference genome and then flipped. This is especially useful 
when conducting a meta-analysis since these variants will then be comparable even though they 
originate from different data sets. If these ambiguous variants are considered to be correctly imputed, 
then the accuracy of imputation with the SIS (AGR) increases to 96% while the accuracy of the 
in-house imputation method increases to 94%. Accuracy and quality can be further improved by 
removing half-matching variants by applying a quality score and MAF filter.  
Since four of the five methods were capable of imputing X-linked variants, and since the quality and 
accuracy of X chromosome imputation has not been previously tested, we included it for this analysis. 
The X chromosome had only slightly lower or higher imputation quality for all imputation runs when 
compared to the autosomes, indicating that X chromosome imputation can be performed with 
confidence (Table 5.2 and 5.3). Although not specifically analysed here, the quality of imputation at 
low MAF should also be noted: the imputation quality for rare variants was unexpected as large 
reference panels with the correct populations are required to accurately impute rare variants (351,352) 
(Figure 5.1). 
The biggest limitation for imputation in the five-way admixed population is the lack of a suitable 
reference panel. Imputation in the San population has been shown to have the lowest imputation 
accuracy (89%) compared to other African populations (345), which could be due to a lack of 
applicable reference individuals. Since the main ancestral component in the SAC population is 
KhoeSan (86) this could affect the accuracy and quality of imputation in this population. However, this 
has improved due to the addition of KhoeSan individuals to the reference panel. 
In conclusion, we have shown that imputation of the SAC population is feasible and produces quality 
data on both the autosomes and X chromosome. While the SIS (AGR) imputation had the best quality 
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and accuracy, the in-house method using Impute2 and 1000G Phase 3 also produced imputed data 
of a high standard and had the highest number of imputed variants. This method may prove especially 
useful in the case of a meta-analysis where one wishes to maximise SNP overlap between datasets. 
As the number of applicable reference populations and individuals grows, imputation accuracy will 
improve for African and admixed populations, but it remains the gold-standard to Sanger sequence a 
variant of interest to confirm that the imputed variant is present in the population prior to conducting 
further research.  
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5.7 Supplementary material 
 
Figure S5.1: Percentage of overlapping variants that match between the imputed and MEGA data 
for different genotype calling thresholds.
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6.1 Abstract 
Globally Tuberculosis (TB) presents with a clear male bias that cannot be completely accounted for 
by environment, behaviour, socioeconomic factors or the impact of sex-hormones on the immune 
system. This suggests that genetic and biological differences, specifically relating to the X 
chromosome, further influence the male sex bias. The X chromosome has been shown to be heavily 
implicated in immune function and yet has largely been ignored in previous association studies. Here 
we report the first X chromosome specific association study on TB susceptibility. We identified X-
linked TB susceptibility variants using seven genotyping datasets and 23229 individuals from different 
ethnic backgrounds. A sex-stratified and combined meta-analysis was conducted using the XWAS 
software and genomic regions previously associated with TB susceptibility were reproduced in this 
study. While significant associations were identified, the genes that they are located in have not 
previously been implicated in TB susceptibility.  
6.2 Introduction 
The X chromosome has been estimated to encode approximately 1500 of the 20000 protein coding 
genes in the human genome (119) and has the highest density of regulatory miRNA (118). This means 
that the X chromosome codes for over 5% of proteins and 10% of miRNA respectively and even 
though many of these are involved in immune functions the X chromosome has generally been 
ignored in previous association studies (353). According to the GWAS catalogue, 62652 unique SNP-
trait associations have been identified by 3420 publications and of these associations only 385 SNPs 
were located on the X chromosome with 157 reaching genome wide significance (p-value < 5e−8) 
(122). This indicates the extent to which the X chromosome has been ignored in GWAS even though 
it represents a significant portion of the genome. In the past this was due to the analysis complexities 
introduced to GWAS by the X chromosome due to the haploid nature of males, but recently tools have 
been developed to analyse this chromosome specifically (114,115). Females have a more robust 
immune response against infections, which is partially attributable to the X chromosome and further 
influenced by the processes of X chromosome inactivation (XCI) and genes that escape silencing 
(139,140,197,235). Given the role of the X chromosome in sex biased immune responses it should 
not be excluded from statistical analysis, especially for infectious diseases, which often presents with 
a male bias, and autoimmune diseases, which often presents with a female bias (168). 
Tuberculosis (TB), caused by Mycobacterium tuberculosis (M. tuberculosis), presents with a strong 
male bias with the global reported incidence rate being nearly twice as high in males compared to 
females (27). This male bias has been shown to be influenced, but not fully explained, by 
socioeconomic and behavioural factors, access to healthcare and the impact of sex hormones 
(estrogen and testosterone) on the immune system (140,143,144). As these factors do not fully 
explain the sex bias we hypothesise that X-linked genes and the process of XCI could further clarify 
the phenomenon. Thirteen published GWAS have investigated TB susceptibility (72,123–127,129–
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131,133,281,292), but only six of these included the X chromosome in their analysis 
(72,96,123,126,133,281) and only one of the studies focused specifically on the X chromosome (281). 
Our previous study revealed strong sex specific effects on both the autosome and X chromosome, 
suggesting that sex-stratified QC and association testing should be done when analysing the X 
chromosome and autosomes (281). These sex-stratified analyses are of vital importance as sex 
specific effects of variants will be lost in a combined analysis which will negate the opposite directions 
of effects between the sexes. As a result of this, vital information concerning TB susceptibility and sex 
bias is lost, highlighting the need for sex-stratified analysis.  
Apart from ignoring the X chromosome, previous studies have also validated poorly across 
populations. This is because ancestry has a major impact on TB susceptibility which has been shown 
in meta-analysis and admixture studies (291,354). Here we report the first X chromosome specific 
sex-stratified meta-analysis to identify TB susceptibility loci and elucidate its male sex bias, using 
GWAS data from European, Asian and African cohorts. Trans-ethnic meta-analyses have the 
advantage of giving us an overview of both population specific and global susceptibility variants and 
helping us to understand how ethnicity and sex influence TB susceptibility. 
6.3 Methods 
6.3.1 Study cohorts  
Data for this meta-analysis was obtained from the International Tuberculosis Host Genetics 
Consortium (ITHGC) (96,123,128,131,355) and published TB GWAS (133,281). The ITHGC consists 
of 14 datasets, but eight cohorts had no X chromosome data or too few X-linked variants for imputation 
and were excluded from the analysis. In total two Asian, one European, two African and two South 
African Coloured (SAC) cohorts were included in this meta-analysis (Table 6.1), with a total of 11632 
cases, 11597 controls and a 1.85:1 male to female ratio. Approval for the study was obtained from 
the Health Research Ethics Committee of Stellenbosch University (project registration number 
S17/01/013 and 95/072).  
Table 6.1: Genotyping platform and number of samples for each cohort prior to quality control and 
imputation. 
Country Ethnicity Cases Controls Females 
(%) 
Platform Source 
China (1) Asian 483 587 28.19 Affymetrix SNP 
Array 6.0 
(128) 
China (2) Asian 1290 1145 48.74 Human 
OmniZhonghua-
8 chips. 
(128) 
Russia European 5914 6022 29.32 Affymetrix 
Genome-Wide 
Human SNP 
Array 6.0  
(123) 
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Country Ethnicity Cases Controls Females 
(%) 
Platform Source 
Gambia African 1316 1382 39.53 Affymetrix 
GeneChip 500K 
(96) 
Ghana African 1359 1952 36.97 Affymetrix SNP 
Array 6.0 
(131) 
SACA SAC 850 90 44.66 Affymetrix 500k (133) 
SACM SAC 420 419 55.78 Illumina MEGA (281) 
 
6.3.2 Quality control and Imputation 
Quality control (QC) prior to imputation was performed as described previously (281), in order to 
obtain high quality genotypes for imputation. Briefly, the XWAS software (v3.0) and pipeline was used 
to implement a sex-stratified QC on all data, removing individuals without sex information and 
relatedness (up to 3rd degree) (114,115). As the datasets had varying coverage of the X chromosome 
due to the different genotyping platforms used (Table 6.1), imputation was done to increase the 
number of overlapping variants for the meta-analysis. An in-house method employing Impute2 (356) 
and the full 1000 Genomes Phase 3 reference panel (81) was used for imputation as previously 
described (Chapter 5), however data was not phased prior to imputation. Phasing was avoided in 
order to increase imputation accuracy (356). Imputed variants were filtered at an info score of 0.45 
and all non-binary variants were removed before converting the data to plink format using GTOOL 
version 0.7.5 (350) at a genotype calling threshold of 0.7. Finally, the data underwent another sex-
stratified QC procedure, using the same parameters as prior to imputation except that sex 
concordance and relatedness was not checked again. Overlapping variants between all datasets 
were extracted for the meta-analysis and aligned to the same reference allele where possible using 
the Plink v1.9 reference-allele command (357).  
6.3.3 Meta-analysis 
The meta-analysis was conducted by combining the association test results for each individual 
dataset using the XWAS (v3.0) software (114,115). A sex-stratified logistic regression test was 
performed for each dataset using the first five principle components as covariates for the ITHGC data 
and the four main ancestral components (Bantu-speaking African, KhoeSan, European and South 
Asian) for the SAC. The SAC was subject to sex biased admixture events and as a result there are 
significant differences between the ancestral components of the autosome and X chromosome. 
Therefore, the Admixture software (version 1.3) was used to determine X chromosome specific 
ancestral components (using the –haploid flag), as described previously (Chapter 3). Association 
statistics for males and females were combined for the sex-stratified meta-analysis to determine sex 
specific effects. In addition, all male and female results were also combined into one meta-analysis 
to determine effects that are independent of sex. This was done in an overall and population stratified 
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manner by testing all seven datasets together, or by grouping the two Asian or African cohorts (SAC, 
Ghana and Gambia). The Chi-squared based Q statistic was used to assess the heterogeneity 
between included studies and for a heterogeneity p-value > 0.1 the fixed effects (FE) model was 
implemented and for p-values ≤ 0.1 the random effects (RE) model was used to calculate pooled odds 
ratio (OR) and p-values (358). Genome wide significance threshold for the meta-analysis was set to 
5e−8 (307).  
6.4 Results 
6.4.1 Cohort summary 
Summary statistics of all the datasets following imputation and QC are shown in Table 6.2. In total 
20255 individuals passed QC (10026 cases and 10229 controls) of which 35% were female. Between 
the different datasets 69983 variants overlapped and aligned to the same reference allele. 
Table 6.2: Cohort summary and number of overlapping variants post Imputation and QC. 
Cohort 
Sample 
size Females Cases 
Cases 
Female Control 
Control 
Female 
SNPs 
before 
imputation 
SNPs after 
imputation 
China1 990 275 434 138 556 137 23907 180228 
China2 2264 1103 1203 551 1061 552 16995 190719 
Gambia 2541 1026 1229 353 1312 673 9305 339775 
Ghana 3002 1112 1269 400 1733 712 32870 514299 
SACA 596 256 577 242 19 14 9419 250838 
SACM 815 465 410 242 405 223 24974 352167 
Russia 10047 2861 4904 1293 5143 1568 28147 231499 
 
6.4.2 Individual association results 
Five genome wide significant variants were identified for the individual datasets (Table 6.3). 
Manhattan and QQ-plot for these results are given in supplementary Figures S6.1 and S6.2. One 
SNP (rs4465088) is located downstream of the actin related protein T1 gene (ACTRT1) in the 
Ghanaian females (OR = 4.73, p-value = 4.53e−18) and in the combined analysis (p-value = 1.60e−16) 
(fishers’ method for combining p-values). ACTRT1 encodes for a protein related to cytoskeletal beta-
actin and while it is also involved in spermatid formation this gene has been shown to have tumour 
suppressive properties. The tumour suppressive properties were identified in basal cell carcinomas 
which result from the aberrant activation of the Hedgehog signalling pathway (359). While these genes 
have not been previously implicated in TB susceptibility the sonic hedgehog pathway (homolog of the 
hedgehog pathway) is implicated in mycobacterial immune evasion mediated through exploitation of 
regulatory T-cells (360).  
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 Four significant variants were identified in the Russian cohort, three of which were significant in males 
(rs6610096, rs7888114, rs2563800), one in females (rs6610096) and two for the combined test 
statistic (rs6610096, rs5975736). The rs6610096 variant, located in the prostate associated gene 4 
(PAGE4) was significant in male, females and the combined analysis. PAGE4 is a member of the 
cancer/testis X antigens and while its function is poorly understood it is a DNA binding protein and 
silencing of PAGE4 in vitro caused cell death by apoptosis, indicating that PAGE4 has an anti-
apoptotic function (361). Expression of PAGE4 is also inversely correlated with cancer progression 
and dysregulation of PAGE4 modulates androgen receptor signalling and promotes progression to 
advanced prostate cancer (362). The rs2563800 variant, significantly associated in males and the 
combined analysis, is located in a non-coding RNA (ncRNA) LOC105373293, with no known function. 
FRMPD4, a gene previously implicated in schizophrenia, was only significantly associated in males 
(rs7888114), while rs5975736, located in the Bombesin Receptor Subtype 3 (BRS3) gene was 
associated in the combined dataset and had the same direction of effect between the sexes (363). 
BRS3 is involved in energy homeostasis and upregulates glucose-stimulated insulin secretion in 
human pancreatic islet cells and could have a potential role in treatment of obesity and diabetes 
mellitus (364,365).  
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Table 6.3: Results for X chromosome association testing of individual datasets. 
SNP Gene (locus) Position A1 
Male Female 
P comb Cohort OR* P-value 95% CI* OR P-value 95%CI 
rs4465088 ACTRT1 (Xq25) 3’UTR G 0.94 8.58e−1 0.46-1.91 4.73 4.53e−18 3.42-6.55 1.60e−16 Ghanaian 
rs6610096 PAGE4 (Xp11.23) 5’UTR A 1.53 9.95e−14 1.37-1.72 1.70 8.95e−16 1.49-1.94 5.84 e−27 Russia 
rs7888114 FRMPD4 (Xp22.2) Intron C 19.29 9.72e−9 7.05-52.8 3.14 1.18e−3 1.57-6.31 3.00 e−10 Russia 
rs2563800 
LOC105373293 
(Xq21.31) 
Intron A 
1.57 1.08e−8 1.35-1.83 1.04 0.659 0.87-1.25 1.41 e−7 Russia 
rs5975736 BRS3 (Xq26.3) 3’UTR A 2.49 6.1e−7 1.74-3.56 2.29 3.43e−5 3.52-49.2 5.36 e−10 Russia 
*OR: Odds ratio; 95% CI: 95% confidence interval 
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6.4.3 Meta-analysis results 
Both a genome wide significance threshold (5e−8) and a Bonferroni threshold (7.14e−7) were 
implemented to correct for the number of variants tested in the meta-analysis (0.05/69983). As TB is 
a complex disease and variants are unlikely to have large effect sizes, lowering the significance 
threshold can help to reduce the loss of valuable information in the form of false negative results. In 
total four variants reached significance in the sex-stratified population specific analysis, while no 
significant associations were identified in the combined (male and female) and sex-stratified analysis 
including all datasets (Table 6.4 and 6.5). The quantile-quantile (QQ) and Manhattan plots for these 
association tests are given in supplementary Figures S6.3-S6.5. The most significantly associated 
variant for the non-sex-stratified analysis including all datasets was rs79720685 (OR = 0.83, p-value 
= 3.06e−5) located in the interleukin 1 receptor accessory protein like 1 (IL1RAPL1) gene (Table 6.4). 
Variants in this gene have been associated with cardiovascular disease (366), autism (367) and 
presented with a male sex bias in a previous XWAS of asthma susceptibility in children (353). Variants 
in IL1RAPL1 downregulate interleukin (IL) 13 which has a negative impact on the IL-1R pathway, a 
potential regulator of inflammation and a critical component of the host innate immune response 
against infections (368). The impact of this gene on TB susceptibility is unclear but given its role in 
the immune response it may contribute to the disease. The top hit for the combined meta-analysis in 
the Chinese cohorts was related to spermatogenesis and thus not informative in the context of TB 
susceptibility (369). For the African cohorts the combined analysis revealed the variant with the lowest 
p-valur to be in the actin remodelling regulator NHS gene, previously associated with Nanca-Horan 
Syndrome (a congenital cataract disease), dental abnormalities, brachymetacarpia (an abnormal 
shortness of the metacarpal bones) and mental retardation (370–373).  
Table 6.4: Meta-analysis results for the combined analysis. 
SNP 
Gene 
(locus) Position A1 N 
P-
value OR* Q Model cohort 
rs79720685 IL1RAPL1 
(Xp21.3-
21.2) 
Intron T 14 3.06e−5 0.83 0.37 Fixed All 
rs58085560 SPANXN2 
(Xq27.3) 
3'UTR C 4 2.85e−5 1.32 0.86 Fixed China 
rs5909376 NHS 
(Xp22.2-
22.13) 
Intron T 8 4.11e−5 1.22 0.63 Fixed African 
SAC 
*OR: Odds ratio 
For the sex-stratified meta-analysis the variants with the lowest p-values in the analysis including all 
cohorts for males was rs753468 (OR_M = 0.84, p-value = 3.21e−5), located in the ATRX gene and 
for females rs7053675 (OR_F = 0.83, p-value = 5.56e−6) located in the PTCHD1-AS gene (Table 
6.5). The chromatin remodeller ATRX plays a role in supressing deleterious DNA secondary 
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structures that form a transcribed telomeric repeat, and loss of function of the ATRX gene can 
increase DNA damage and stall replication and homology-directed repair (374). This suggests that 
ATRX is involved in essential biological processes and it has been previously implicated in intellectual 
disability and osteosarcoma (375). Disruptions of the PTCHD1-AS gene are prevalent in ~1% of 
Autism spectrum disorders and intellectual disabilities (376). For the Chinese cohorts the sex-stratified 
analysis revealed 3 genome wide significant associations (rs1726176, rs5939510, rs1726203) in the 
long intergenic non-protein coding RNA 1546 (LINCO1546) in males, while no significant associations 
were identified in females. The close proximity of these variants in LINC01546 suggest LD between 
the variants and it is unclear if any of the variants influence TB susceptibility as no functional 
information is available for the LINC01546 locus. Finally, in the African cohorts one variant, in the 
UPF3B gene, reached significance in females after Bonferroni correction (rs2428212, OR_F = 2.03, 
p-value = 4.72e−7) but not in males. UPF3B is a regulator of nonsense mediated mRNA decay (NMD) 
and rapidly breaks down aberrant mRNA with a premature termination codon (PTC). UPF3B is 
involved in a central step in RNA surveillance by regulating crosstalk between the NMD pathway and 
the PTC-bound ribosome complex (377). Mutations in the UPF3B gene disrupt the NMD pathway, 
which is critical for neuronal development and can cause various forms of intellectual disability (378–
380). While this gene has not previously been implicated in TB susceptibility, it could influence disease 
by altering RNA regulation linked to host defence against TB.   
Table 6.5: Meta-analysis results for the sex-stratified analysis. 
SNP 
Gene 
(locus) Position A1 N 
Male Female 
Q (M/F) Model Cohort OR* P OR P 
rs753468 ATRX 
(Xq21.1) 
Intron C 7 0.84 3.21e−5 1.06 1.62e−1 0.42/0.66 Fixed All 
rs7053675 PTCHD1-
AS 
(Xp22.11) 
Intron A 7 1.05 2.11e−1 0.83 5.56e−6 0.15/0.01 Fixed All 
rs1726176 LINC01546 
(Xp22.33) 
3'UTR A 7 1.82 4.20e−8 0.97 7.19e−1 0.80/0.75 Fixed China 
rs5939510 LINC01546 
(Xp22.33) 
3'UTR A 7 1.82 4.89e−8 0.98 7.50e−1 0.79/0.74 Fixed China 
rs1726203 LINC01546 
(Xp22.33) 
3'UTR G 7 1.81 6.37e−8 0.97 6.92e−1 0.86/0.69 Fixed China 
rs2428212 UPF3B 
(Xq24) 
Intron C 7 0.76 2.28e−1 2.03 4.72e−7 0.95/0.15 Fixed African 
SAC 
*OR: Odds ratio 
6.5 Discussion 
Here we report the first X chromosome specific meta-analysis to investigate human genetic 
susceptibility to TB and the observed male bias. While no susceptibility variants reached significance 
in the meta-analysis including all cohorts, four sex-stratified variants were identified in the population 
stratified analysis, three variants for males in the Chinese cohorts and one variant in females in the 
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African cohorts (Table 6.5). Analysis of the individual data also revealed five significant associations 
in the Ghanaian and Russian datasets (Table 6.3). While most of the genes identified in this study 
have not been previously implicated in TB susceptibility a few could potentially be involved in 
mechanisms associated with the disease. ACTR1, IL1RAPL1, ATRX and UPF3B are involved in 
cellular functions that could be linked to host defence against TB. ACTR1 and IL1RAPL1 are involved 
in immune pathways via the sonic hedgehog signalling pathway and IL-1R pathway respectively, and 
mutations can affect T-cell regulation (360) and host immune response to infection (368), both of 
which are involved in host defence against TB. ATRX and UPF3B are involved in essential biological 
processes by monitoring and controlling aberrant RNA that could negatively impact transcription and 
RNA regulation (374,377). The role of these genes in immune function and RNA regulation suggests 
that they could impact TB susceptibility, but further investigation is required to elucidate the functional 
mechanisms underlying our statistical findings. Previous TB susceptibility studies investigating X-
linked genes have identified several TLR8 variants, but these associations were not replicated in this 
study (132,134–138). Possible reasons for this could be the impact of population specific effects and 
more stringent significance thresholds. However, while the exact variants and genes previously 
identified with TB susceptibility on the X chromosome were not replicated the genomic regions where 
these genes are located did replicate. In a linkage study the genomic region Xq, specifically Xq26, 
was associated with TB susceptibility in an African cohort (69). Indirect evidence of TB susceptibility 
loci on the X chromosome has also been provided from studies in Mendelian susceptibility to 
mycobacterial diseases (MSMD) where two X-linked regions, Xp11.4-Xp21.2 and Xq25-26.3 have 
been associated with MSMD (381,382). All these genomic regions were validated in this study, as 
well as the genomic locus where TLR8 is situated (Xp22). We identified significant associations at 
Xp11.23, Xp21-Xp22.33, Xq21 and Xq24-Xq27.3, which overlap with previously associated genomic 
regions. This suggests that these genomic regions are implicated in TB susceptibility, but further 
research and fine-mapping is required to elucidate which genes and variants in this region contribute 
to the phenotype. Many X-linked genes have not been fully characterised, and their functions are still 
unclear; a recurring theme in our study. As a result, the impact on TB susceptibility cannot be 
elucidated using bioinformatic analysis alone and functional analysis of the genes is required. This is 
a major limitation in XWAS as many significant associations cannot be fully elucidated without 
functional verification, due to the lack of information about X-linked genes and their involvement in 
biological mechanisms. The impact of a variant on gene function can be tested by introducing the 
variant into an appropriate cell line (in vitro) or animal model (in vivo) using genomic editing methods 
such as CRISPR (383,384). Infection studies using these edited cell lines or animals can be done to 
determine the function of the variant.  
A second conclusion that can be drawn from these results is that there are strong population specific 
effects influencing TB susceptibility. The fact that no significant associations were identified, even 
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though the study has more power when all data is included, supports this hypothesis. Previous studies 
in admixed populations have also shown increased susceptibility for some ancestral components over 
others (354). While larger studies may identify global susceptibility variants the impact of ethnicity on 
TB susceptibility cannot be ignored and population stratified analysis must be performed to elucidate 
the full complexity of TB disease. In the era of personalised medicine this will also be of vital 
importance as medication can be tailored and targeted for specific population groups and sexes (385). 
We have shown in a previous XWAS in the SAC population (281) that strong sex specific effects exist, 
and this is mirrored in this study. When comparing the OR of males and females (Table 6.3 and 6.5) 
it is clear that many sex-specific variants have opposite directions of effect or a negligible effect in 
one of the sexes. We found 6 significant associations in males but only 3 in females and none in the 
combined analysis, making a strong case for sex specific effects.  
We suggest that during the planning of TB susceptibility studies, power should be determined based 
on the sample size of one sex, to maintain enough statistical power for sex-stratified analysis. 
Furthermore, care should be taken during sample selection to minimise population specific effects 
and subsequent larger and more powerful trans-ethnic meta-analysis will need to be performed to 
identify global susceptibility variants. Identifying population specific, sex-specific and global 
susceptibility variants can elucidate some of the complexity of TB pathogenesis and eventually allow 
for tailored or even preventative treatment. 
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6.7 Supplementary material 
 
Figure S6.1: Manhattan and QQ-plot for X-linked SNP association testing of the Ghanaian cohort. 
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Figure S6.2: Manhattan and QQ-plot for X-linked SNP association testing of the Russian cohort. 
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Figure S6.3: Manhattan and QQ-plot for the X-linked meta-analysis of the Chinese cohorts. 
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Figure S6.4: Manhattan and QQ-plot for the X-linked meta-analysis of the African cohorts, including 
the Gambian, Ghanaian and SAC data. 
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Figure S6.5: Manhattan and QQ-plot for the X-linked meta-analysis including all cohorts. 
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7 General discussion and conclusion 
7.1 Summary 
Sex-bias in diseases is present from infancy and persists across age groups, suggesting that it is 
independent of sex hormones, behaviour and environment and thus must have a host genetic 
contributing factor. Incidence rates for many infectious diseases (bacterial, fungal, viral and parasitic) 
persistently presents with a male sex-bias regardless of age, while auto-immune diseases present 
with a female bias (140,212,386,387). Significant sex differences in pharmacokinetics and 
pharmacodynamics of drugs have also been reported for men, women and pregnant females (388). 
It is thus important to understand the interplay of disease susceptibility factors and the genes on the 
sex chromosomes to discover novel pathways that will inform the understanding of disease, its sex-
bias and the search for solutions.    
The work presented in this thesis investigates the genetic contribution to the observed male sex-bias 
of TB. Globally the TB notification rate is nearly twice as high in males compared to females (27). We 
hypothesise that this bias is in part caused by X-linked genes and the unique biology of the X 
chromosome. Females are diploid for X-linked genes and males are haploid, which leads to the 
random inactivation of one X chromosome in females (148). This random inactivation makes females 
functional mosaics for X-linked genes and could give them an immunological advantage, driving the 
sex-bias. Flaws in the inactivation process such as genes that escape silencing and skewed 
inactivation could further influence the observed sex-bias.  
Based on the possible involvement of the X chromosome, we reviewed (Chapter 2) past literature to 
determine the involvement of the X chromosome and X-linked genes in the immune system. The X 
chromosome contains a wealth of genomic information and a large number of X-linked genes have 
immune-related functions (118,119). The process of X chromosome inactivation (XCI) was also 
discussed along with the mechanisms and causes for genes escaping silencing and skewed 
inactivation and how this could influence disease susceptibility. As behaviour, socioeconomic factors 
and sex hormones also influence the male sex-bias in TB these factors were considered and it was 
concluded that while they influence the sex-bias they do not fully explain it, further supporting the role 
of the X chromosome (140,143,144). As females have been shown to have a more robust immune 
response against infection, the role of the X chromosome and sex-bias in infectious diseases, caused 
by bacteria, fungi, parasites and viruses is discussed (144). The role of the X chromosome was also 
discussed in the context of TB and evidence strongly suggestive of the role of the X chromosome in 
TB susceptibility and the observed male bias was presented.  
Admixed populations, such as the South African Coloured population, add another level of complexity 
to X-linked analysis. Admixture can be sex-biased and result in significantly different ancestral 
distributions on the autosome compared to the X chromosome. Thus, the presence of sex-biased 
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admixture and its influence on TB susceptibility needs to be investigated (Chapter 3). A previous 
study has elucidated the presence of sex-biased admixture events in the history of the SAC using 
mtDNA and Y chromosomal markers (389). In this chapter an alternative method for determining sex-
bias using global ancestry proportions inferred separately for the X chromosome and autosome was 
implemented (146,147). We show that there are significant differences in global admixture proportions 
between the autosome and X chromosome in the SAC population. The Bantu-speaking African and 
the European ancestral component present with a male bias, while the KhoeSan and Asian ancestral 
components present with a female bias. These results correlate perfectly with previous results (389) 
and highlight the importance of using X chromosome and autosomal ancestral components as 
covariates for association testing of the X chromosome and autosome respectively. The results also 
validate the global ancestry approach for determining the presence of sex-bias in this admixed 
population.  
Using the ancestral components inferred in Chapter 3, a sex-stratified GWAS was performed in the 
SAC population using the Illumina MEGA array, a genotyping array specifically tailored for diverse 
populations (Chapter 4). A sex-stratified autosomal and X chromosome specific QC procedure was 
implemented followed by sex-stratified and combined association testing on the autosome and X 
chromosome (114,115). A gene-based association test as well as a sex differentiation test was also 
performed for X-linked genes. We also conducted the first genome wide interaction analysis using a 
joint effects model, followed by interaction analysis of the top 450 associations using a logistic 
regression model, correcting for age and ancestry. While the SNP based association analysis did not 
reveal any significant results, the interaction analysis identified genes that showed promise as 
potential future candidate genes. Finally, this GWAS showed that strong sex specific effects are 
evident for both autosomal and X-linked genes, highlighting the importance of conducting sex-
stratified analysis.  
Due to the lack of power in the GWAS study (Chapter 4) and the availability of additional GWAS data 
through our collaboration with the International Tuberculosis Host Genetics Consortium (ITHGC) an 
X-linked multi-ethnic meta-analysis was done to investigate TB susceptibility and its sex-bias 
(Chapter 6). In order to ensure maximal SNP overlap between all the datasets and increase power, 
we needed to impute the data. While multiple methods for imputation are readily available, none have 
been tested or optimised for our 5-way admixed SAC population. To address this an analysis was 
performed to assess the quality and accuracy of imputation in the SAC using various software and 
reference datasets (Chapter 5). Results from this analysis indicated that the SAC population can be 
imputed on both the X chromosome and autosome with adequate quality and accuracy. Determining 
imputation performance in this population is an important step as the SA population presents with a 
much more complex admixture pattern than previously investigated admixed populations such as 
African Americans and Hispanics. Furthermore, the KhoeSan and African founder populations of the 
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SA are under-investigated, and less data is available for imputation in these populations compared to 
European and Asian populations. Thus, knowing that we can accurately impute the SA population 
allows us to include these datasets in meta-analysis and increase power to detect associations by 
increasing the number of variants to be tested (Chapter 6).  
In total seven datasets were included for this first ever meta-analysis investigating X-linked variants 
in TB susceptibility. Two Chinese, one Russian, a Gambian and Ghanaian and two SAC cohorts were 
included with 69983 overlapping variants left for analysis following imputation. All datasets went 
through a sex-stratified QC procedure (as discussed in Chapter 4) and again a sex-stratified and 
combined X-linked SNP based association test was done. Firstly, association testing was done on all 
individual datasets, revealing five novel associations in the Ghanaian and Russian cohorts. While no 
significant associations were identified in the combined and sex-stratified meta-analysis including all 
datasets, two significant associations were discovered in Chinese males when the meta-analysis was 
stratified by population. The genes identified in this meta-analysis have not been previously 
associated with TB and while some have limited functional information available a few potential 
candidate genes (ACTR1, IL1RAPL1, ATRX and UPF3B) that could influence TB susceptibility were 
identified but require further investigation. While these genes have not been previously associated 
with disease progression, the genomic regions in which they are located are known TB susceptibility 
loci (Xp11.23, Xp21-Xp22.33, Xq21 and Xq24-Xq27.3) (132,138,265,381,382,390). The meta-
analysis also indicated the strength of population specific effects in TB susceptibility and this could 
explain why no significant associations were identified in the analysis including all cohorts. 
Furthermore, as for the GWAS (Chapter 4), the meta-analysis revealed sex-specific effects that could 
potentially influence the male sex-bias in TB susceptibility.  
Overall these studies highlight the importance of conducting sex-stratified analysis and including 
appropriate covariates for X-linked association testing, due to the presence of sex-biased admixture. 
Furthermore, imputation in diverse populations was shown to have good quality and accuracy allowing 
for their inclusion in meta-analysis. Results from the association testing highlight the strong impact of 
population specific and sex-specific effects and a few potential candidate genes were identified, which 
warrant further investigation to elucidate their impact on TB susceptibility and the male sex-bias it 
presents with.  
7.2 Limitations and future work 
While the work conducted in this thesis revealed novel insights some clear limitations are evident and 
need to be addressed in future studies.  
The first limitation is the power to detect significant associations, which is based on the sample size 
of the study. The complexity of TB, population specific effects and the sample size reduction due to 
splitting the data for sex-stratified analysis also negatively impacts on the results. TB is a complex 
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disease and as with most complex diseases effects of individual variants are likely to be small (77,79). 
Furthermore, there is unlikely to be a single causative variant and it is more likely that multiple variants 
with small effect collectively influence TB susceptibility. This polygenic nature means that each 
individual is likely to carry a number of variants that increase susceptibility and a number of variants 
that decrease susceptibility (79). This means that each individual could potentially carry a unique set 
of alleles that collectively influence susceptibility and while software has been developed to detect 
these interactions (gene-gene interaction analysis) they require immensely powerful studies in order 
to overcome the multiple testing burden (79,93) (as in Chapter 4). Furthermore, as GWAS are 
designed based on the analysis of common variants the impact of rare variants on disease 
susceptibility cannot be elucidated (79).  
The second factor influencing power is the reduction of sample size due to the sex-stratified analysis. 
Due to the genetic nature of the X chromosome males and females need to be analysed separately, 
which reduces sample size and power. Furthermore, the fact that males are haploid for X-linked genes 
further reduces power compared to their female counterparts. As this thesis has shown, strong sex 
specific effects are present on not only the X chromosome but autosome as well (Chapter 4 and 6), 
suggesting that sex-stratified analyses are vital to fully elucidate TB susceptibility. This issue of 
reduced power in sex-stratified analysis can be rectified by doubling the sample size and ensuring 
that sufficient power to detect associations is available in one sex of the study. However, sample 
collection is difficult and expensive and thus not always feasible. Alternative methods to increase 
sample size, such as meta-analysis, need to be explored.  
The third factor influencing power, especially in a meta-analysis, is population specific effects. 
Ancestry has been shown to influence TB susceptibility and genetic associations have replicated 
poorly across different populations (1,99,333,391). Africans are more susceptible to TB, while 
Europeans are more resistant as a result of longer historic pressure by the disease (64). These 
population specific effects can affect the meta-analysis if specific ethnic groups have different 
directions of effect for a particular SNP, which would reduce the effect of that variant in a multi-ethnic 
meta-analysis. The same variant could be significantly associated with disease in a population 
stratified analysis or GWAS, which is what we observed for our meta-analysis (Chapter 6). Despite 
this, meta-analyses are valuable for the study of TB susceptibility as they could identify associated 
variants across all populations but will likely require more power than currently available.  
When analysing the results of the GWAS and meta-analysis (Chapter 4 and 6) another limitation 
comes to light and that is the lack of functional characterisation and annotation of X-linked genes. 
Many of the associations identified in this study are in uncharacterised genes or genes with very 
limited functional information. It is thus difficult to decipher how an associated gene could impact TB 
susceptibility without functional verification. This lack of information for X-linked genes is a direct result 
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of the X chromosome being ignored in past association studies, a practice that needs to change if the 
function and impact of X-linked variants are to be deciphered.   
Other limiting factors, not specific to this thesis, but rather to GWAS in general, could also have 
affected the outcome of the analysis. SNP arrays require prior knowledge of the genome to design 
probes and incomplete annotation can influence array effectiveness (95). This is particularly true for 
the long-ignored X chromosome. SNP arrays are also limited to non-repetitive sequences in the 
genome which complicates analysis of related genes and alternatively spliced transcripts and copy 
number variations (CNVs) (95). The PCR based amplification methods for microarray genotyping can 
also introduce biases that influence the results. The specific strain of M. tuberculosis and its virulence 
also influences TB susceptibility, but strain information was not available for this thesis and as such 
could not be taken into account.  
Future work should thus focus on reducing the impact of the limitations mentioned above. Larger 
sample sizes will reduce the power loss in sex-stratified analysis and allow for detection of small effect 
sizes. Also, as the number of TB GWAS studies increases, more data will be available to conduct 
powerful meta-analyses to identify both general and population specific associations. While these 
steps can improve the outcome of GWAS and GWAS-based meta-analysis they will not negate the 
limitations of the SNP microarrays in general. One way to overcome these limitations is by conducting 
next generation sequencing (NGS) instead. NGS requires no prior knowledge of the genome and can 
capture more genetic variation than GWAS. NGS is also not limited to non-repetitive sequences and 
can easily annotate related genes, alternative splicing and CNVs. PCR amplification is also reduced 
or eliminated in NGS and thus no amplification-based biases can be introduced. Finally, sequencing 
data is a powerful detection tool for rare variants which cannot be detected by GWAS but could 
influence disease susceptibility.  
While NGS could address many of the problems facing GWAS there are limitations to conducting 
large NGS studies. Sequencing is still expensive compared to GWAS and a definite limiting factor 
especially in a resource constrained setting. Furthermore, NGS data is extremely large and requires 
a massive amount of storage space and computational power to analyse, further increasing the cost 
associated with NGS analysis. As a result, GWAS is still an invaluable analytic tool especially when 
large sample sizes are to be analysed, which is the case when conducting a pTB GWAS study. More 
severe phenotypes of TB are likely caused by rare variants and thus large sample sizes will be needed 
when doing GWAS, or NGS must be done to capture these rare variants in smaller sample sizes. 
GWAS can also serve as a screening tool to collect a priori evidence before conducting an expensive 
NGS analysis. While the price of NGS will continue to decrease, SNP arrays are still more robust than 
sequencing and will continue to bring valuable insight to disease aetiology (79). Furthermore, some 
analysis tools originally developed for GWAS have already been adapted and used in NGS data 
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analysis. Analytical tools and computational methodologies developed for GWAS represent a 
significant scientific advancement that will ultimately aid in the analysis of NGS data, which is 
generally more difficult to analyse (75).  
The fact that NGS analysis adapted tools from GWAS brings to light another detrimental factor caused 
by excluding the X chromosome. If analytical tools for the X chromosome are not developed and 
improved then they will not be adopted for general use by the scientific community, thus hindering 
advancement of X-linked analysis. This will also translate to a lack of analytical tools and knowledge 
of how to analyse X-linked NGS data and could cause the X chromosome to be excluded from NGS 
studies as it was for GWAS. X chromosomal analysis should be encouraged and become an 
indispensable part of data analysis. This alone will lead to methodological advances and allow full 
utilisation of both GWAS and NGS data.  
7.3 Conclusion 
Since the advent of GWAS, SNP arrays have improved, as did computational methodologies and the 
amount of publicly available data, allowing for analyses such as ancestry inference, imputation and 
meta-analysis. The fact that the X chromosome was mostly excluded in GWAS caused the number 
of X chromosomal analysis tools and functional X-linked gene annotation to be far lower compared to 
the autosome. In future, focus will need to shift from data analysis to functional annotation to link 
GWAS results to biological function and fully understand disease aetiology. Furthermore, X 
chromosome analysis tools must be incorporated in GWAS pipelines as this is the only way to get the 
methods generally accepted and used by the scientific community. 
In conclusion, this thesis highlights the need for sex-stratified and X-linked analysis and the methods 
presented here should encourage other researchers to include the X chromosome in any future 
analysis. Only by including the X chromosome in GWAS analysis will we improve the X-linked analysis 
tools and elucidate the role of the X chromosome in disease susceptibility. This study revealed strong 
sex and population specific effects that need to be accounted for in the study design to retain sufficient 
power for sex-stratified analysis. Future, more powerful meta-analysis will also need to be done to 
identify general and population specific susceptibility loci. This thesis thus presents clear evidence for 
the involvement of the X chromosome in TB susceptibility and the male sex-bias and future studies 
will need to focus on elucidating these effects. Fully understanding the sex-biased nature of TB will 
allow for medication tailored to a specific sex, which could improve treatment outcome. Furthermore, 
identifying population specific and globally associated variants could also lead to population specific 
and general treatment regimes and ultimately improve the global health status.  
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